Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-10-03 14:46 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,713
+160 vol $10.71 each |
11,273 | |
Filed 2024-10-03 14:45 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+320 vol |
11,113 | |
Filed 2024-10-01 22:31 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,634.0064
-1,952 vol $10.57 each |
33,853 | |
Filed 2024-10-01 22:28 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,820.8097
-261 vol $10.81 each |
35,805 | |
Filed 2024-10-01 13:51 Tx date 2024-08-26 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+9,060 vol |
9,060 | |
Filed 2024-10-01 13:49 Tx date 2024-06-17 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-10-01 11:33 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,822
+637 vol $10.71 each |
177,256 | |
Filed 2024-10-01 11:32 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,275 vol |
176,619 | |
Filed 2024-10-01 10:27 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$3,148
+294 vol $10.71 each |
11,685 | |
Filed 2024-10-01 10:24 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-588 vol |
11,391 | |
Filed 2024-09-18 14:54 Tx date 2024-06-17 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-09-24 10:21 Tx date 2024-09-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-390.25
-35 vol $11.15 each |
177,894 | |
Filed 2024-09-24 10:20 Tx date 2024-09-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,660
-600 vol $11.10 each |
177,929 | |
Filed 2024-09-23 11:34 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-27,473.55
-2,509 vol $10.95 each |
45,529 | |
Filed 2024-09-23 11:16 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-22,272
-2,320 vol $9.60 each |
3,516 | |
Filed 2024-09-23 11:11 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,674.80
-2,984 vol $10.95 each |
48,038 | |
Filed 2024-09-23 11:10 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,528
+2,984 vol $8.22 each |
51,022 | |
Filed 2024-09-23 11:07 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-24,528.48
-2,984 vol $8.22 each |
532 | |
Filed 2024-09-23 11:01 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,404
-2,320 vol $10.95 each |
48,038 | |
Filed 2024-09-23 11:00 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$22,272
+2,320 vol $9.60 each |
50,358 | |
Filed 2024-09-23 10:57 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-22,656
-2,360 vol $9.60 each |
||
Filed 2024-09-23 10:57 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-22,656
-2,360 vol $9.60 each |
3,476 | |
Filed 2024-09-18 14:54 Tx date 2024-06-17 |
$RX
BioSyent Inc. |
MCCORMICK, MARNIE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,060 | ||
Filed 2024-09-03 20:42 Tx date 2024-07-23 |
$RX
BioSyent Inc. |
Driscoll, Merrilyn Joy
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,025,000
-500,000 vol $10.05 each |
1,646,100 | |
Filed 2024-09-03 20:40 Tx date 2024-07-23 |
$RX
BioSyent Inc. |
Driscoll, Sean
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,025,000
-500,000 vol $10.05 each |
1,646,100 | |
Filed 2024-09-03 20:37 Tx date 2024-07-23 |
$RX
BioSyent Inc. |
Driscoll, Blair
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,025,000
-500,000 vol $10.05 each |
1,646,100 | |
Filed 2024-09-03 20:34 Tx date 2024-07-23 |
$RX
BioSyent Inc. |
Federated Capital Corp.
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,025,000
-500,000 vol $10.05 each |
1,646,100 | |
Filed 2024-09-03 20:31 Tx date 2024-07-23 |
$RX
BioSyent Inc. |
FAX Investments Inc.
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,025,000
-500,000 vol $10.05 each |
1,646,100 | |
Filed 2024-09-03 20:28 Tx date 2024-07-23 |
$RX
BioSyent Inc. |
FAX Capital Corp.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,025,000
-500,000 vol $10.05 each |
1,646,100 | |
Filed 2024-08-06 16:29 Tx date 2024-07-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
97 - Other
|
$10,870
+1,087 vol $10.00 each |
195,759 | |
Filed 2024-07-04 11:29 Tx date 2024-07-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,590
+159 vol $10.00 each |
10,793 | |
Filed 2024-07-04 11:28 Tx date 2024-07-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+319 vol |
10,634 | |
Filed 2024-07-04 07:14 Tx date 2024-07-02 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,350
+635 vol $10.00 each |
178,529 | |
Filed 2024-07-04 07:13 Tx date 2024-07-02 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,270 vol |
177,894 | |
Filed 2024-07-03 11:12 Tx date 2024-07-02 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$2,930
+293 vol $10.00 each |
11,979 | |
Filed 2024-07-03 11:10 Tx date 2024-07-02 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-586 vol |
11,686 | |
Filed 2024-06-30 21:03 Tx date 2024-06-28 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,246.92
-423 vol $10.04 each |
36,066 | |
Filed 2024-06-21 10:24 Tx date 2024-06-20 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,024.70
-1,900 vol $10.01 each |
36,489 | |
Filed 2024-06-21 10:22 Tx date 2024-06-20 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,520.35
-1,850 vol $10.01 each |
38,389 | |
Filed 2024-06-21 10:20 Tx date 2024-06-20 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,566.497
-1,755 vol $10.01 each |
40,239 | |
Filed 2024-06-17 18:46 Tx date 2024-06-12 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,276.36
-1,522 vol $9.38 each |
997,970 | |
Filed 2024-06-17 18:41 Tx date 2024-06-12 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$11,338
+1,522 vol $7.45 each |
335,867 | |
Filed 2024-06-07 10:15 Tx date 2024-05-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,000 vol |
10,800 | |
Filed 2024-06-07 10:14 Tx date 2024-05-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,100 vol |
12,800 | |
Filed 2024-06-07 10:11 Tx date 2024-05-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,673
+1,000 vol $8.67 each |
14,900 | |
Filed 2024-06-07 10:10 Tx date 2024-05-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,645
+1,000 vol $8.64 each |
13,900 | |
Filed 2024-06-07 10:09 Tx date 2024-05-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,500
+1,000 vol $8.50 each |
12,900 | |
Filed 2024-06-07 10:08 Tx date 2024-05-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,110
+4,000 vol $8.53 each |
11,900 | |
Filed 2024-06-07 10:06 Tx date 2024-05-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,500
+1,000 vol $8.50 each |
7,900 | |
Filed 2024-06-07 10:05 Tx date 2024-05-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$850.00
+100 vol $8.50 each |
6,900 | |
Filed 2024-06-07 10:04 Tx date 2024-05-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$49,990
+5,800 vol $8.62 each |
6,800 | |
Filed 2024-05-28 17:17 Tx date 2024-05-24 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-7,902.72
-882 vol $8.96 each |
64,782 | |
Filed 2024-05-22 19:58 Tx date 2024-05-22 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,866.40
-432 vol $8.95 each |
179,164 | |
Filed 2024-05-22 19:57 Tx date 2024-05-22 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,800
-200 vol $9.00 each |
179,596 | |
Filed 2024-05-08 12:21 Tx date 2024-04-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
97 - Other
|
$-9,393.89
-1,081 vol $8.69 each |
174,672 | |
Filed 2024-05-08 12:19 Tx date 2024-03-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
97 - Other
|
$-238,110.50
-28,013 vol $8.50 each |
175,753 | |
Filed 2024-05-08 12:10 Tx date 2024-04-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,627
+5,100 vol $8.55 each |
194,672 | |
Filed 2024-05-08 12:09 Tx date 2024-04-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$59,213
+6,900 vol $8.58 each |
189,572 | |
Filed 2024-05-08 12:07 Tx date 2024-04-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$69,030
+8,000 vol $8.63 each |
182,672 | |
Filed 2024-05-08 11:49 Tx date 2024-04-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-800 vol |
1,000 | |
Filed 2024-05-08 11:48 Tx date 2024-04-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-6,200 vol |
1,800 | |
Filed 2024-05-08 11:41 Tx date 2024-04-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,500
+1,000 vol $8.50 each |
8,000 | |
Filed 2024-05-08 11:40 Tx date 2024-04-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,759
+800 vol $8.45 each |
7,000 | |
Filed 2024-05-08 11:38 Tx date 2024-04-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,500
+1,000 vol $8.50 each |
6,200 | |
Filed 2024-05-08 11:37 Tx date 2024-04-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,500
+1,000 vol $8.50 each |
5,200 | |
Filed 2024-05-08 11:32 Tx date 2024-04-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,498
+1,000 vol $8.50 each |
4,200 | |
Filed 2024-05-08 11:29 Tx date 2024-04-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,486
+1,000 vol $8.49 each |
3,200 | |
Filed 2024-05-08 11:27 Tx date 2024-04-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,100
+600 vol $8.50 each |
2,200 | |
Filed 2024-05-08 11:23 Tx date 2024-04-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,500
+1,000 vol $8.50 each |
1,600 | |
Filed 2024-05-08 11:22 Tx date 2024-04-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,100
+600 vol $8.50 each |
600 | |
Filed 2024-04-08 16:18 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-53,000 vol |
0 | |
Filed 2024-04-08 16:14 Tx date 2024-03-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$158,950
+18,700 vol $8.50 each |
53,000 | |
Filed 2024-04-08 16:13 Tx date 2024-03-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,875
+2,500 vol $8.75 each |
34,300 | |
Filed 2024-04-08 16:11 Tx date 2024-03-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,625
+2,500 vol $8.65 each |
31,800 | |
Filed 2024-04-08 16:09 Tx date 2024-03-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,625
+2,500 vol $8.65 each |
29,300 | |
Filed 2024-04-08 16:07 Tx date 2024-03-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,625
+2,500 vol $8.65 each |
26,800 | |
Filed 2024-04-08 16:05 Tx date 2024-03-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,500
+2,500 vol $8.60 each |
24,300 | |
Filed 2024-04-08 16:02 Tx date 2024-03-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,699
+2,500 vol $8.68 each |
21,800 | |
Filed 2024-04-08 16:01 Tx date 2024-03-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,625
+2,500 vol $8.65 each |
19,300 | |
Filed 2024-04-08 15:58 Tx date 2024-03-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,675
+2,500 vol $8.67 each |
16,800 | |
Filed 2024-04-08 15:56 Tx date 2024-03-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$43,240
+5,000 vol $8.65 each |
14,300 | |
Filed 2024-04-08 15:55 Tx date 2024-03-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,472
+2,400 vol $8.53 each |
9,300 | |
Filed 2024-04-08 15:52 Tx date 2024-03-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$851.00
+100 vol $8.51 each |
6,900 | |
Filed 2024-04-02 18:36 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+17,103 vol |
999,492 | |
Filed 2024-04-02 18:35 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$79,305
+9,330 vol $8.50 each |
982,389 | |
Filed 2024-04-02 18:34 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-18,661 vol |
973,059 | |
Filed 2024-04-02 18:28 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,974
+1,164 vol $7.71 each |
991,720 | |
Filed 2024-04-02 18:27 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$20,343
+2,625 vol $7.75 each |
990,556 | |
Filed 2024-04-02 11:25 Tx date 2024-04-01 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,492
+632 vol $8.69 each |
179,796 | |
Filed 2024-04-02 11:23 Tx date 2024-04-01 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,264 vol |
179,164 | |
Filed 2024-04-02 09:56 Tx date 2024-04-01 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,373
+158 vol $8.69 each |
10,315 | |
Filed 2024-04-02 09:55 Tx date 2024-04-01 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+317 vol |
10,157 | |
Filed 2024-04-02 09:32 Tx date 2024-04-01 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$2,528
+291 vol $8.69 each |
12,272 | |
Filed 2024-04-02 09:30 Tx date 2024-04-01 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-583 vol |
11,981 | |
Filed 2024-03-30 09:00 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,293 vol |
9,840 | |
Filed 2024-03-29 14:02 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,195 vol |
17,502 | |
Filed 2024-03-29 14:01 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,637
+1,722 vol $8.50 each |
14,307 | |
Filed 2024-03-29 14:00 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-3,444 vol |
12,585 | |
Filed 2024-03-28 17:29 Tx date 2024-03-28 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,837.20
-556 vol $8.70 each |
180,428 | |
Filed 2024-03-28 15:35 Tx date 2024-03-28 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,000 vol $8.70 each |
9,684 | |
Filed 2024-03-28 15:32 Tx date 2024-03-28 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,000 vol $8.70 each |
8,684 | |
Filed 2024-03-28 14:35 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,671 vol |
41,994 | |
Filed 2024-03-28 10:03 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,193 vol |
2,600 | |
Filed 2024-03-28 09:33 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,074 vol |
48,038 | |
Filed 2024-03-28 08:48 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+6,438 vol |
52,730 | |
Filed 2024-03-28 08:45 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,108 vol |
20,175 | |
Filed 2024-03-28 07:55 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,074 vol |
65,664 | |
Filed 2024-03-27 20:03 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+5,173 vol |
180,984 | |
Filed 2024-03-27 19:48 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,385 vol |
12,564 | |
Filed 2024-03-27 19:20 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$57,689
+6,631 vol $8.70 each |
56,254 | |
Filed 2024-03-27 12:36 Tx date 2024-03-26 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,220
-600 vol $8.70 each |
175,811 | |
Filed 2024-03-27 07:03 Tx date 2024-03-24 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$19,278
+2,268 vol $8.50 each |
61,590 | |
Filed 2024-03-27 07:01 Tx date 2024-03-20 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-4,537 vol |
59,322 | |
Filed 2024-03-27 06:57 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,166
+281 vol $7.71 each |
63,859 | |
Filed 2024-03-27 06:55 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,772
+1,261 vol $7.75 each |
63,578 | |
Filed 2024-03-25 13:07 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,166
+281 vol $7.71 each |
46,233 | |
Filed 2024-03-25 13:04 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$18,088
+2,337 vol $7.74 each |
45,952 | |
Filed 2024-03-25 08:03 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+440 vol |
49,814 | |
Filed 2024-03-25 08:01 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+1,444 vol |
49,374 | |
Filed 2024-03-25 07:58 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,521 vol |
44,408 | |
Filed 2024-03-25 07:56 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,043 vol |
40,887 | |
Filed 2024-03-24 10:00 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$770.28
+98 vol $7.86 each |
7,680 | |
Filed 2024-03-24 09:59 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,616
+211 vol $7.66 each |
7,582 | |
Filed 2024-03-21 14:10 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$19,278
+2,268 vol $8.50 each |
41,346 | |
Filed 2024-03-21 14:05 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-4,537 vol |
39,078 | |
Filed 2024-03-20 16:00 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$840.72
+113 vol $7.44 each |
8,751 | |
Filed 2024-03-20 15:59 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,971
+649 vol $7.66 each |
8,638 | |
Filed 2024-03-20 15:55 Tx date 2024-01-04 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,222
+136 vol $8.99 each |
||
Filed 2024-03-20 15:55 Tx date 2023-12-20 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$61.95
+7 vol $8.85 each |
||
Filed 2024-03-20 15:55 Tx date 2023-10-13 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,218
+151 vol $8.07 each |
||
Filed 2024-03-20 15:55 Tx date 2023-09-19 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$54.95
+7 vol $7.85 each |
||
Filed 2024-03-20 15:55 Tx date 2023-07-06 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,145
+153 vol $7.49 each |
||
Filed 2024-03-20 15:54 Tx date 2023-06-20 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$43.86
+6 vol $7.31 each |
||
Filed 2024-03-20 15:54 Tx date 2023-04-11 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,221
+161 vol $7.59 each |
||
Filed 2024-03-20 15:54 Tx date 2023-03-17 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$36.50
+5 vol $7.30 each |
||
Filed 2024-03-20 15:53 Tx date 2023-01-18 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,130
+151 vol $7.49 each |
||
Filed 2024-03-20 13:53 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$12,197
+1,435 vol $8.50 each |
17,067 | |
Filed 2024-03-20 13:51 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,870 vol |
15,632 | |
Filed 2024-03-20 13:48 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,491
+194 vol $7.69 each |
18,502 | |
Filed 2024-03-20 13:45 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,347
+948 vol $7.75 each |
18,308 | |
Filed 2024-03-20 12:58 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$17,569
+2,067 vol $8.50 each |
38,323 | |
Filed 2024-03-20 12:56 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,134 vol |
36,256 | |
Filed 2024-03-20 12:52 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,960
+253 vol $7.75 each |
32,122 | |
Filed 2024-03-20 12:48 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,284
+1,069 vol $7.75 each |
31,869 | |
Filed 2024-03-20 09:08 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$31,246
+3,676 vol $8.50 each |
49,623 | |
Filed 2024-03-20 09:07 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,352 vol |
45,947 | |
Filed 2024-02-09 14:04 Tx date 2024-01-04 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,222
+136 vol $8.99 each |
||
Filed 2024-02-09 14:01 Tx date 2023-12-20 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$61.95
+7 vol $8.85 each |
||
Filed 2024-02-09 13:59 Tx date 2023-10-13 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,218
+151 vol $8.07 each |
||
Filed 2024-02-09 13:57 Tx date 2023-09-19 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$54.95
+7 vol $7.85 each |
||
Filed 2024-02-09 13:56 Tx date 2023-07-06 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,145
+153 vol $7.49 each |
||
Filed 2024-02-09 13:54 Tx date 2023-06-20 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$43.86
+6 vol $7.31 each |
||
Filed 2024-02-09 13:53 Tx date 2023-04-11 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,221
+161 vol $7.59 each |
||
Filed 2024-02-09 13:50 Tx date 2023-03-17 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$36.50
+5 vol $7.30 each |
||
Filed 2024-02-09 13:48 Tx date 2023-01-18 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,130
+151 vol $7.49 each |
||
Filed 2024-03-19 13:01 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,842
+245 vol $7.52 each |
11,246 | |
Filed 2024-03-19 11:27 Tx date 2024-03-15 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,078
+403 vol $7.64 each |
176,411 | |
Filed 2024-03-19 10:07 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,673
+217 vol $7.71 each |
16,029 | |
Filed 2024-03-19 10:06 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,602
+981 vol $7.75 each |
15,812 | |
Filed 2024-03-19 09:40 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,509
+454 vol $7.73 each |
53,299 | |
Filed 2024-03-19 09:39 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$28,582
+3,688 vol $7.75 each |
52,845 | |
Filed 2024-03-08 13:40 Tx date 2024-02-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-13,200 vol |
6,800 | |
Filed 2024-03-08 13:39 Tx date 2024-02-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-37,500 vol |
17,500 | |
Filed 2024-03-08 13:36 Tx date 2024-02-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,584
+2,500 vol $8.63 each |
20,000 | |
Filed 2024-03-08 13:34 Tx date 2024-02-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,851
+4,300 vol $8.57 each |
55,000 | |
Filed 2024-03-08 13:33 Tx date 2024-02-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,846
+2,200 vol $8.57 each |
50,700 | |
Filed 2024-03-08 13:32 Tx date 2024-02-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$49,194
+5,700 vol $8.63 each |
48,500 | |
Filed 2024-03-08 13:31 Tx date 2024-02-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,541
+300 vol $8.47 each |
42,800 | |
Filed 2024-03-08 13:29 Tx date 2024-02-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$43,300
+5,000 vol $8.66 each |
42,500 | |
Filed 2024-03-08 13:28 Tx date 2024-02-16 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,750
+2,500 vol $8.70 each |
37,500 | |
Filed 2024-03-08 13:27 Tx date 2024-02-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,737
+2,500 vol $8.69 each |
35,000 | |
Filed 2024-03-08 13:26 Tx date 2024-02-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,875
+2,500 vol $8.75 each |
32,500 | |
Filed 2024-03-08 13:24 Tx date 2024-02-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,835
+2,500 vol $8.73 each |
30,000 | |
Filed 2024-03-08 13:22 Tx date 2024-02-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$39,335
+4,500 vol $8.74 each |
27,500 | |
Filed 2024-03-08 13:21 Tx date 2024-02-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,330
+500 vol $8.66 each |
23,000 | |
Filed 2024-03-08 13:20 Tx date 2024-02-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,710
+2,500 vol $8.68 each |
22,500 | |
Filed 2024-03-08 13:18 Tx date 2024-02-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,498
+2,800 vol $8.75 each |
20,000 | |
Filed 2024-03-08 13:15 Tx date 2024-02-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,986
+2,200 vol $8.63 each |
17,200 | |
Filed 2024-03-08 13:14 Tx date 2024-02-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,500
+2,500 vol $8.60 each |
15,000 | |
Filed 2024-03-08 13:12 Tx date 2024-02-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,495
+2,500 vol $8.60 each |
12,500 | |
Filed 2024-03-08 13:09 Tx date 2024-02-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,500
+2,500 vol $8.60 each |
10,000 | |
Filed 2024-01-06 08:38 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,540
+1,066 vol $8.95 each |
6,922 | |
Filed 2024-01-06 08:31 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,133 vol |
5,856 | |
Filed 2024-01-03 12:37 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,346
+1,156 vol $8.95 each |
176,008 | |
Filed 2024-01-03 12:35 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,313 vol |
174,852 | |
Filed 2024-01-03 11:28 Tx date 2003-10-30 |
$RX
Hedley Technologies Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$25,000
+100,000 vol $0.25 each |
||
Filed 2024-01-03 11:25 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,586
+289 vol $8.95 each |
8,238 | |
Filed 2024-01-03 11:24 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,506
+280 vol $8.95 each |
||
Filed 2024-01-03 11:23 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+578 vol |
7,949 | |
Filed 2024-01-03 10:48 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$9,540
+1,066 vol $8.95 each |
9,934 | |
Filed 2024-01-03 10:45 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,133 vol |
8,868 | |
Filed 2024-01-03 09:58 Tx date 2023-12-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-68,700 vol |
6,000 | |
Filed 2024-01-03 09:57 Tx date 2023-12-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$53,641
+6,000 vol $8.94 each |
74,700 | |
Filed 2024-01-03 09:56 Tx date 2023-12-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$29,205
+3,300 vol $8.85 each |
68,700 | |
Filed 2024-01-03 09:55 Tx date 2023-12-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$92,750
+10,600 vol $8.75 each |
65,400 | |
Filed 2024-01-03 09:55 Tx date 2023-12-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,723
+200 vol $8.62 each |
54,800 | |
Filed 2024-01-03 09:54 Tx date 2023-12-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$194,967
+22,800 vol $8.55 each |
54,600 | |
Filed 2024-01-03 09:53 Tx date 2023-12-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$83,298
+9,800 vol $8.50 each |
31,800 | |
Filed 2024-01-03 09:53 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,800
+2,000 vol $8.40 each |
22,000 | |
Filed 2024-01-03 09:52 Tx date 2023-12-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$93,240
+11,100 vol $8.40 each |
20,000 | |
Filed 2024-01-03 09:51 Tx date 2023-12-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,285
+4,100 vol $8.36 each |
8,900 | |
Filed 2024-01-03 09:46 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
97 - Other
|
$-32,014.15
-3,577 vol $8.95 each |
203,766 | |
Filed 2024-01-03 09:45 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
97 - Other
|
$-27,958.02
-3,557 vol $7.86 each |
207,343 | |
Filed 2004-04-20 10:21 Tx date 2003-10-30 |
$RX
Hedley Technologies Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$25,000
+100,000 vol $0.25 each |
||
Filed 2004-04-14 14:23 Tx date 2003-10-30 |
$RX
Hedley Technologies Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
+100,000 vol |
||
Filed 2023-12-08 17:09 Tx date 2023-12-08 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-49,300
-5,800 vol $8.50 each |
43,615 | |
Filed 2023-12-08 17:08 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-70,958
-8,348 vol $8.50 each |
49,415 | |
Filed 2023-12-08 17:07 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,300
+2,762 vol $7.35 each |
57,763 | |
Filed 2023-12-08 17:06 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,443
+2,007 vol $6.20 each |
55,001 | |
Filed 2023-12-08 17:05 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-20,300.70
-2,762 vol $7.35 each |
5,836 | |
Filed 2023-12-08 17:04 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-12,443.40
-2,007 vol $6.20 each |
8,598 | |
Filed 2023-12-08 17:02 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,663
+3,579 vol $7.45 each |
52,994 | |
Filed 2023-12-08 16:59 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$26,663
+3,579 vol $7.45 each |
14,184 | |
Filed 2023-12-08 16:59 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$26,663
+3,579 vol $7.45 each |
||
Filed 2023-12-08 16:58 Tx date 2023-12-06 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-26,663.55
-3,579 vol $7.45 each |
10,605 | |
Filed 2023-12-04 11:25 Tx date 2023-11-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-18,700 vol |
4,800 | |
Filed 2023-12-04 11:24 Tx date 2023-11-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$40,320
+4,800 vol $8.40 each |
23,500 | |
Filed 2023-12-04 11:23 Tx date 2023-11-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$820.00
+100 vol $8.20 each |
18,700 | |
Filed 2023-12-04 11:23 Tx date 2023-11-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$820.00
+100 vol $8.20 each |
18,600 | |
Filed 2023-12-04 11:22 Tx date 2023-11-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$147,659
+18,000 vol $8.20 each |
18,500 | |
Filed 2023-12-04 11:22 Tx date 2023-11-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$775.00
+100 vol $7.75 each |
500 | |
Filed 2023-12-04 11:21 Tx date 2023-11-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,100
+400 vol $7.75 each |
400 | |
Filed 2023-11-29 14:50 Tx date 2023-11-27 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,500
-1,000 vol $8.50 each |
49,415 | |
Filed 2023-11-29 14:49 Tx date 2023-11-27 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,450
+1,000 vol $7.45 each |
50,415 | |
Filed 2023-11-29 14:47 Tx date 2023-11-27 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-7,450
-1,000 vol $7.45 each |
14,184 | |
Filed 2023-10-05 17:51 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,339
+1,061 vol $7.86 each |
7,989 | |
Filed 2023-10-05 17:48 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,123 vol |
6,928 | |
Filed 2023-10-05 07:27 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,023
+1,148 vol $7.86 each |
177,165 | |
Filed 2023-10-05 07:25 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,297 vol |
176,017 | |
Filed 2023-10-04 13:43 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$8,339
+1,061 vol $7.86 each |
11,001 | |
Filed 2023-10-04 13:40 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,123 vol |
9,940 | |
Filed 2023-10-04 09:14 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,255
+287 vol $7.86 each |
107,371 | |
Filed 2023-09-05 16:03 Tx date 2023-08-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-39,300 vol |
0 | |
Filed 2023-09-05 16:03 Tx date 2023-08-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,084
+3,700 vol $7.59 each |
39,300 | |
Filed 2023-09-05 16:02 Tx date 2023-08-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,952
+2,900 vol $7.57 each |
35,600 | |
Filed 2023-09-05 16:02 Tx date 2023-08-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,456
+4,800 vol $7.60 each |
32,700 | |
Filed 2023-09-05 16:01 Tx date 2023-08-16 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,320
+700 vol $7.60 each |
27,900 | |
Filed 2023-09-05 16:00 Tx date 2023-08-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,080
+800 vol $7.60 each |
27,200 | |
Filed 2023-09-05 15:59 Tx date 2023-08-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,800
+500 vol $7.60 each |
26,400 | |
Filed 2023-09-05 15:59 Tx date 2023-08-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,320
+700 vol $7.60 each |
25,900 | |
Filed 2023-09-05 15:58 Tx date 2023-08-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,440
+1,900 vol $7.60 each |
25,200 | |
Filed 2023-09-05 15:57 Tx date 2023-08-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$760.00
+100 vol $7.60 each |
23,300 | |
Filed 2023-09-05 15:57 Tx date 2023-08-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,239
+4,400 vol $7.55 each |
23,200 | |
Filed 2023-09-05 15:56 Tx date 2023-08-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,440
+1,900 vol $7.60 each |
18,800 | |
Filed 2023-09-05 15:55 Tx date 2023-08-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,040
+800 vol $7.55 each |
16,900 | |
Filed 2023-09-05 15:54 Tx date 2023-08-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,480
+4,800 vol $7.60 each |
16,100 | |
Filed 2023-09-05 15:54 Tx date 2023-08-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,954
+4,600 vol $7.60 each |
11,300 | |
Filed 2023-08-08 11:28 Tx date 2023-07-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-46,100 vol |
6,700 | |
Filed 2023-08-08 11:27 Tx date 2023-07-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,428
+1,800 vol $7.46 each |
52,800 | |
Filed 2023-08-08 11:27 Tx date 2023-07-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,400
+1,500 vol $7.60 each |
51,000 | |
Filed 2023-08-08 11:26 Tx date 2023-07-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,600
+1,000 vol $7.60 each |
49,500 | |
Filed 2023-08-08 11:25 Tx date 2023-07-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,070
+2,400 vol $7.53 each |
48,500 | |
Filed 2023-08-08 11:24 Tx date 2023-07-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,140
+2,800 vol $7.55 each |
46,100 | |
Filed 2023-08-08 11:24 Tx date 2023-07-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$31,258
+4,200 vol $7.44 each |
43,300 | |
Filed 2023-08-08 11:23 Tx date 2023-07-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,920
+1,600 vol $7.45 each |
39,100 | |
Filed 2023-08-08 11:22 Tx date 2023-07-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$745.00
+100 vol $7.45 each |
37,500 | |
Filed 2023-08-08 11:21 Tx date 2023-07-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,458
+4,600 vol $7.49 each |
37,400 | |
Filed 2023-08-08 11:21 Tx date 2023-07-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,110
+1,600 vol $7.57 each |
32,800 | |
Filed 2023-08-08 11:20 Tx date 2023-07-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,800
+3,000 vol $7.60 each |
31,200 | |
Filed 2023-08-08 11:19 Tx date 2023-07-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,306
+700 vol $7.58 each |
28,200 | |
Filed 2023-08-08 11:18 Tx date 2023-07-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,899
+3,700 vol $7.54 each |
27,500 | |
Filed 2023-08-08 11:18 Tx date 2023-07-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$29,960
+4,000 vol $7.49 each |
23,800 | |
Filed 2023-08-08 11:17 Tx date 2023-07-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$35,520
+4,800 vol $7.40 each |
19,800 | |
Filed 2023-08-08 11:16 Tx date 2023-07-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$35,760
+4,800 vol $7.45 each |
15,000 | |
Filed 2023-08-08 11:16 Tx date 2023-07-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$35,951
+4,800 vol $7.49 each |
10,200 | |
Filed 2023-07-05 10:32 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
97 - Other
|
$-26,529.58
-3,542 vol $7.49 each |
210,900 | |
Filed 2023-07-05 10:31 Tx date 2023-06-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$73,725
+10,000 vol $7.37 each |
214,442 | |
Filed 2023-07-05 10:30 Tx date 2023-06-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,939
+6,800 vol $7.34 each |
204,442 | |
Filed 2023-07-05 10:29 Tx date 2023-06-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$59,259
+8,200 vol $7.23 each |
197,642 | |
Filed 2023-07-05 10:28 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
97 - Other
|
$-388,935
-51,858 vol $7.50 each |
189,442 | |
Filed 2023-07-05 10:09 Tx date 2023-06-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-163,500 vol |
5,400 | |
Filed 2023-07-05 10:08 Tx date 2023-06-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$39,859
+5,400 vol $7.38 each |
168,900 | |
Filed 2023-07-05 10:07 Tx date 2023-06-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$271,990
+37,000 vol $7.35 each |
163,500 | |
Filed 2023-07-05 10:07 Tx date 2023-06-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,474
+200 vol $7.37 each |
126,500 | |
Filed 2023-07-05 10:06 Tx date 2023-06-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,160
+5,300 vol $7.20 each |
126,300 | |
Filed 2023-07-05 10:05 Tx date 2023-06-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$74,880
+10,400 vol $7.20 each |
121,000 | |
Filed 2023-07-05 10:04 Tx date 2023-06-16 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,360
+3,800 vol $7.20 each |
110,600 | |
Filed 2023-07-05 10:04 Tx date 2023-06-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,840
+2,200 vol $7.20 each |
106,800 | |
Filed 2023-07-05 10:03 Tx date 2023-06-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,760
+3,300 vol $7.20 each |
104,600 | |
Filed 2023-07-05 10:03 Tx date 2023-06-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$319,725
+43,500 vol $7.35 each |
101,300 | |
Filed 2023-07-05 10:02 Tx date 2023-06-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$42,630
+5,800 vol $7.35 each |
57,800 | |
Filed 2023-07-05 10:01 Tx date 2023-06-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$198,450
+27,000 vol $7.35 each |
52,000 | |
Filed 2023-07-05 10:01 Tx date 2023-06-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,760
+1,200 vol $7.30 each |
25,000 | |
Filed 2023-07-05 10:00 Tx date 2023-06-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$66,394
+8,900 vol $7.46 each |
23,800 | |
Filed 2023-07-05 09:59 Tx date 2023-06-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$67,104
+9,000 vol $7.46 each |
14,900 | |
Filed 2023-07-05 09:59 Tx date 2023-06-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,820
+1,200 vol $7.35 each |
5,900 | |
Filed 2023-07-05 09:58 Tx date 2023-06-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,190
+300 vol $7.30 each |
4,700 | |
Filed 2023-07-04 12:38 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,909
+1,056 vol $7.49 each |
9,051 | |
Filed 2023-07-04 12:36 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,112 vol |
7,995 | |
Filed 2023-07-04 09:01 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,142
+286 vol $7.49 each |
107,084 | |
Filed 2023-07-04 09:00 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+573 vol |
106,798 | |
Filed 2023-07-01 08:15 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,568
+1,144 vol $7.49 each |
178,314 | |
Filed 2023-07-01 08:14 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,289 vol |
177,170 | |
Filed 2023-06-30 17:52 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$7,909
+1,056 vol $7.49 each |
12,063 | |
Filed 2023-06-30 17:43 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,112 vol |
11,007 | |
Filed 2023-06-12 09:25 Tx date 2023-06-02 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-7,996.80
-1,088 vol $7.35 each |
62,317 | |
Filed 2023-06-11 17:33 Tx date 2023-06-09 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,000 vol |
47,930 | |
Filed 2023-06-07 20:46 Tx date 2023-06-06 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,000 vol |
46,930 | |
Filed 2023-06-06 09:06 Tx date 2023-05-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,650
+500 vol $7.30 each |
4,400 | |
Filed 2023-06-06 09:05 Tx date 2023-05-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,470
+3,900 vol $7.30 each |
3,900 | |
Filed 2023-05-10 10:46 Tx date 2023-04-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-9,500 vol |
0 | |
Filed 2023-05-10 10:45 Tx date 2023-04-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,250
+5,000 vol $7.25 each |
9,500 | |
Filed 2023-04-10 10:44 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-48,300 vol |
4,500 | |
Filed 2023-04-10 10:43 Tx date 2023-03-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,750
+4,500 vol $7.50 each |
52,800 | |
Filed 2023-04-10 10:42 Tx date 2023-03-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$45,640
+6,100 vol $7.48 each |
48,300 | |
Filed 2023-04-10 10:41 Tx date 2023-03-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$186,377
+25,100 vol $7.43 each |
42,200 | |
Filed 2023-04-10 10:40 Tx date 2023-03-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$76,500
+10,200 vol $7.50 each |
17,100 | |
Filed 2023-04-10 10:39 Tx date 2023-03-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$50,848
+6,900 vol $7.37 each |
6,900 | |
Filed 2023-04-05 17:55 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+19,147 vol |
987,931 | |
Filed 2023-04-04 16:09 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$26,002
+3,467 vol $7.50 each |
17,360 | |
Filed 2023-04-04 16:08 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,382
+2,451 vol $7.50 each |
13,893 | |
Filed 2023-04-04 16:07 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-36,765
-4,902 vol $7.50 each |
11,442 | |
Filed 2023-04-03 11:18 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,587 vol |
49,415 | |
Filed 2023-04-03 10:40 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,997 vol |
14,831 | |
Filed 2023-04-03 10:11 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,133 vol |
30,800 | |
Filed 2023-04-03 10:10 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,529 vol |
26,667 | |
Filed 2023-04-03 10:10 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,058 vol |
23,138 | |
Filed 2023-04-03 10:04 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,133 vol |
30,196 | |
Filed 2023-04-03 10:03 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,529 vol |
26,063 | |
Filed 2023-04-03 10:01 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,058 vol |
22,534 | |
Filed 2023-04-03 09:09 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,409 vol |
106,225 | |
Filed 2023-04-02 14:38 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+5,633 vol |
174,881 | |
Filed 2023-04-02 14:36 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,138 vol |
169,248 | |
Filed 2023-04-02 14:34 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,277 vol |
168,110 | |
Filed 2023-04-01 12:17 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,051 vol |
10,107 | |
Filed 2023-04-01 12:15 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,102 vol |
9,056 | |
Filed 2023-04-01 08:40 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$29,040
+3,872 vol $7.50 each |
63,405 | |
Filed 2023-04-01 08:37 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,744 vol |
59,533 | |
Filed 2023-03-31 18:40 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+7,430 vol |
49,157 | |
Filed 2023-03-31 18:39 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$47,047
+6,273 vol $7.50 each |
41,727 | |
Filed 2023-03-31 18:37 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-12,546 vol |
35,454 | |
Filed 2023-03-31 18:12 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,600 vol |
13,119 | |
Filed 2023-03-31 18:02 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,591
+366 vol $7.08 each |
968,784 | |
Filed 2023-03-31 17:59 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,757
+2,074 vol $8.08 each |
968,418 | |
Filed 2023-03-31 17:59 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+7,219 vol |
45,930 | |
Filed 2023-03-31 17:39 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,012 vol |
38,711 | |
Filed 2023-03-31 17:38 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-12,024 vol |
32,699 | |
Filed 2023-03-31 17:31 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,882
+1,051 vol $7.50 each |
15,151 | |
Filed 2023-03-31 17:28 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,102 vol |
10,519 | |
Filed 2023-03-31 17:27 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$22,057
+2,941 vol $7.50 each |
17,828 | |
Filed 2023-03-31 17:26 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-5,882 vol |
14,887 | |
Filed 2023-03-31 17:02 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$29,040
+3,872 vol $7.50 each |
44,828 | |
Filed 2023-03-31 16:59 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,744 vol |
40,956 | |
Filed 2023-03-27 09:42 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+137 vol |
44,723 | |
Filed 2023-03-27 09:37 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+1,162 vol |
44,586 | |
Filed 2023-03-24 17:00 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
$501.97
+71 vol $7.07 each |
12,621 | |
Filed 2023-03-24 16:59 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$727.18
+103 vol $7.06 each |
170,387 | |
Filed 2023-03-22 12:25 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,016
+143 vol $7.11 each |
48,000 | |
Filed 2023-03-22 12:23 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$24,243
+2,993 vol $8.10 each |
47,857 | |
Filed 2023-03-20 11:34 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$332.29
+47 vol $7.07 each |
11,158 | |
Filed 2023-03-20 11:32 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,444
+531 vol $8.37 each |
11,111 | |
Filed 2023-03-15 11:33 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$627.45
+89 vol $7.05 each |
67,277 | |
Filed 2023-03-15 11:32 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,063
+998 vol $8.08 each |
67,188 | |
Filed 2023-03-15 09:56 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$204.45
+29 vol $7.05 each |
104,816 | |
Filed 2023-03-15 09:54 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,275
+152 vol $8.39 each |
104,787 | |
Filed 2023-03-14 11:28 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$570.40
+80 vol $7.13 each |
15,476 | |
Filed 2023-03-14 11:25 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,169
+884 vol $8.11 each |
15,396 | |
Filed 2023-03-13 16:53 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$410.64
+58 vol $7.08 each |
16,344 | |
Filed 2023-03-13 16:50 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$627.45
+89 vol $7.05 each |
48,700 | |
Filed 2023-03-13 16:48 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,495
+681 vol $8.07 each |
16,286 | |
Filed 2023-03-13 16:45 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,838
+1,953 vol $8.11 each |
48,611 | |
Filed 2023-03-13 15:29 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$480.76
+68 vol $7.07 each |
20,769 | |
Filed 2023-03-13 15:27 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,285
+777 vol $8.09 each |
20,701 | |
Filed 2022-12-05 10:08 Tx date 2022-11-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-31,000 vol |
0 | |
Filed 2022-12-05 10:07 Tx date 2022-11-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,172
+1,800 vol $7.32 each |
31,000 | |
Filed 2022-12-05 10:06 Tx date 2022-11-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,701
+2,100 vol $7.48 each |
29,200 | |
Filed 2022-12-05 10:05 Tx date 2022-11-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,500
+2,900 vol $7.41 each |
27,100 | |
Filed 2022-12-05 10:04 Tx date 2022-11-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,942
+2,900 vol $7.22 each |
24,200 | |
Filed 2022-12-05 10:04 Tx date 2022-11-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,867
+2,200 vol $7.21 each |
21,300 | |
Filed 2022-12-05 10:03 Tx date 2022-11-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,987
+2,900 vol $6.89 each |
19,100 | |
Filed 2022-12-05 10:02 Tx date 2022-11-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,250
+2,900 vol $6.98 each |
16,200 | |
Filed 2022-12-05 10:02 Tx date 2022-11-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,475
+2,900 vol $7.41 each |
13,300 | |
Filed 2022-12-05 10:01 Tx date 2022-11-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,725
+2,900 vol $7.49 each |
10,400 | |
Filed 2022-12-05 10:01 Tx date 2022-11-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,890
+2,900 vol $7.55 each |
7,500 | |
Filed 2022-12-05 10:00 Tx date 2022-11-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,680
+800 vol $7.10 each |
4,600 | |
Filed 2022-11-10 11:56 Tx date 2022-11-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,900 vol |
3,800 | |
Filed 2022-11-10 11:56 Tx date 2022-10-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-30,900 vol |
7,700 | |
Filed 2022-11-10 11:55 Tx date 2022-10-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,454
+2,900 vol $7.05 each |
38,600 | |
Filed 2022-11-10 11:54 Tx date 2022-10-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,318
+900 vol $7.02 each |
35,700 | |
Filed 2022-11-10 11:54 Tx date 2022-10-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,024
+1,000 vol $7.02 each |
34,800 | |
Filed 2022-11-10 11:53 Tx date 2022-10-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,574
+2,900 vol $7.09 each |
33,800 | |
Filed 2022-11-10 11:52 Tx date 2022-10-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,595
+2,900 vol $7.45 each |
30,900 | |
Filed 2022-11-10 11:52 Tx date 2022-10-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,210
+2,900 vol $7.31 each |
28,000 | |
Filed 2022-11-10 11:51 Tx date 2022-10-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,784
+2,900 vol $7.17 each |
25,100 | |
Filed 2022-11-10 11:51 Tx date 2022-10-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,975
+1,100 vol $7.25 each |
22,200 | |
Filed 2022-11-10 11:50 Tx date 2022-10-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,929
+2,900 vol $7.22 each |
21,100 | |
Filed 2022-11-10 11:49 Tx date 2022-10-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,828
+400 vol $7.07 each |
18,200 | |
Filed 2022-11-10 11:49 Tx date 2022-10-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,545
+2,900 vol $6.74 each |
17,800 | |
Filed 2022-11-10 11:45 Tx date 2022-10-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,374
+2,900 vol $7.72 each |
14,900 | |
Filed 2022-11-10 11:45 Tx date 2022-10-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,275
+2,100 vol $7.75 each |
12,000 | |
Filed 2022-11-10 11:44 Tx date 2022-10-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,200
+800 vol $7.75 each |
9,900 | |
Filed 2022-11-10 11:43 Tx date 2022-10-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,101
+1,200 vol $7.58 each |
9,100 | |
Filed 2022-11-10 11:43 Tx date 2022-10-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,700
+2,900 vol $7.48 each |
7,900 | |
Filed 2022-11-10 11:42 Tx date 2022-10-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,370
+2,900 vol $7.71 each |
5,000 | |
Filed 2022-10-07 09:01 Tx date 2022-09-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-4,000 vol |
2,100 | |
Filed 2022-10-07 09:01 Tx date 2022-09-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-22,600 vol |
6,100 | |
Filed 2022-10-07 09:00 Tx date 2022-09-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,680
+600 vol $7.80 each |
28,700 | |
Filed 2022-10-07 08:59 Tx date 2022-09-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,625
+1,500 vol $7.75 each |
28,100 | |
Filed 2022-10-07 08:58 Tx date 2022-09-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,880
+4,000 vol $7.72 each |
26,600 | |
Filed 2022-10-07 08:58 Tx date 2022-09-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$125,242
+16,200 vol $7.73 each |
22,600 | |
Filed 2022-10-07 08:57 Tx date 2022-09-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,920
+2,700 vol $7.75 each |
6,400 | |
Filed 2022-09-09 09:46 Tx date 2022-08-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-78,300 vol |
3,700 | |
Filed 2022-09-09 09:45 Tx date 2022-08-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$29,550
+3,700 vol $7.99 each |
82,000 | |
Filed 2022-09-09 09:43 Tx date 2022-08-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$31,192
+3,900 vol $8.00 each |
78,300 | |
Filed 2022-09-09 09:43 Tx date 2022-08-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$72,619
+9,100 vol $7.98 each |
74,400 | |
Filed 2022-09-09 09:42 Tx date 2022-08-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$31,982
+4,000 vol $8.00 each |
65,300 | |
Filed 2022-09-09 09:41 Tx date 2022-08-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,794
+600 vol $7.99 each |
61,300 | |
Filed 2022-09-09 09:40 Tx date 2022-08-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$31,986
+4,000 vol $8.00 each |
60,700 | |
Filed 2022-09-09 09:40 Tx date 2022-08-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$64,000
+8,000 vol $8.00 each |
56,700 | |
Filed 2022-09-09 09:39 Tx date 2022-08-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,000
+2,500 vol $8.00 each |
48,700 | |
Filed 2022-09-09 09:39 Tx date 2022-08-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$64,020
+8,000 vol $8.00 each |
46,200 | |
Filed 2022-09-09 09:38 Tx date 2022-08-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,204
+400 vol $8.01 each |
38,200 | |
Filed 2022-09-09 09:37 Tx date 2022-08-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$801.00
+100 vol $8.01 each |
37,800 | |
Filed 2022-09-09 09:37 Tx date 2022-08-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,000
+3,000 vol $8.00 each |
37,700 | |
Filed 2022-09-09 09:36 Tx date 2022-08-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,873
+3,900 vol $7.92 each |
34,700 | |
Filed 2022-09-09 09:36 Tx date 2022-08-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,960
+1,000 vol $7.96 each |
30,800 | |
Filed 2022-09-09 09:35 Tx date 2022-08-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,752
+1,600 vol $7.97 each |
29,800 | |
Filed 2022-09-09 09:29 Tx date 2022-08-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$215,989
+27,000 vol $8.00 each |
28,200 | |
Filed 2022-09-09 09:27 Tx date 2022-08-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$46,818
+5,850 vol $8.00 each |
241,300 | |
Filed 2022-09-09 09:27 Tx date 2022-08-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$26,550
+3,325 vol $7.99 each |
235,450 | |
Filed 2022-08-10 16:16 Tx date 2022-07-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,396
+2,675 vol $8.00 each |
232,125 | |
Filed 2022-08-10 16:15 Tx date 2022-07-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$26,747
+3,350 vol $7.98 each |
229,450 | |
Filed 2022-08-10 16:13 Tx date 2022-07-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-25,000 vol |
1,200 | |
Filed 2022-08-10 16:12 Tx date 2022-07-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,600
+1,200 vol $8.00 each |
26,200 | |
Filed 2022-08-10 16:11 Tx date 2022-07-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-50,800 vol |
25,000 | |
Filed 2022-08-10 16:10 Tx date 2022-07-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$200,220
+25,000 vol $8.01 each |
75,800 | |
Filed 2022-08-10 16:09 Tx date 2022-07-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$801.00
+100 vol $8.01 each |
50,800 | |
Filed 2022-08-10 16:09 Tx date 2022-07-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,408
+800 vol $8.01 each |
50,700 | |
Filed 2022-08-10 16:08 Tx date 2022-07-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,015
+1,500 vol $8.01 each |
49,900 | |
Filed 2022-08-10 16:07 Tx date 2022-07-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,632
+3,200 vol $8.01 each |
48,400 | |
Filed 2022-08-10 16:06 Tx date 2022-07-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$37,497
+4,700 vol $7.98 each |
45,200 | |
Filed 2022-08-10 16:05 Tx date 2022-07-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,418
+1,800 vol $8.01 each |
40,500 | |
Filed 2022-08-10 16:04 Tx date 2022-07-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,397
+4,800 vol $8.00 each |
38,700 | |
Filed 2022-08-10 16:04 Tx date 2022-07-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,821
+2,100 vol $8.01 each |
33,900 | |
Filed 2022-08-10 16:03 Tx date 2022-07-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,204
+400 vol $8.01 each |
31,800 | |
Filed 2022-08-10 16:02 Tx date 2022-07-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,408
+1,300 vol $8.01 each |
31,400 | |
Filed 2022-08-10 16:02 Tx date 2022-07-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,995
+1,000 vol $8.00 each |
30,100 | |
Filed 2022-07-10 08:42 Tx date 2022-06-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$212,127
+27,200 vol $7.80 each |
29,100 | |
Filed 2022-07-10 08:42 Tx date 2022-06-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,801
+1,900 vol $7.79 each |
1,900 | |
Filed 2022-07-10 08:41 Tx date 2022-06-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-900 vol |
0 | |
Filed 2022-07-10 08:40 Tx date 2022-06-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,975
+900 vol $7.75 each |
900 | |
Filed 2022-07-10 08:40 Tx date 2022-06-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-28,100 vol |
0 | |
Filed 2022-07-10 08:39 Tx date 2022-06-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$35,946
+4,500 vol $7.99 each |
28,100 | |
Filed 2022-07-10 08:38 Tx date 2022-06-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,642
+4,200 vol $8.01 each |
23,600 | |
Filed 2022-07-10 08:38 Tx date 2022-06-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,826
+2,600 vol $8.01 each |
19,400 | |
Filed 2022-07-10 08:37 Tx date 2022-06-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$56,871
+7,100 vol $8.01 each |
16,800 | |
Filed 2022-07-10 08:36 Tx date 2022-06-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,408
+800 vol $8.01 each |
9,700 | |
Filed 2022-07-10 08:35 Tx date 2022-06-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$56,871
+7,100 vol $8.01 each |
8,900 | |
Filed 2022-07-10 08:35 Tx date 2022-06-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,418
+1,800 vol $8.01 each |
1,800 | |
Filed 2022-07-04 10:33 Tx date 2022-06-30 |
$RX
BioSyent Inc. |
Driscoll, Sean
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$194,750
+25,000 vol $7.79 each |
2,146,100 | |
Filed 2022-07-04 10:31 Tx date 2022-06-30 |
$RX
BioSyent Inc. |
Driscoll, Merrilyn Joy
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$194,750
+25,000 vol $7.79 each |
2,146,100 | |
Filed 2022-07-04 10:29 Tx date 2022-06-30 |
$RX
BioSyent Inc. |
Federated Capital Corp.
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$194,750
+25,000 vol $7.79 each |
2,146,100 | |
Filed 2022-07-04 10:26 Tx date 2022-06-30 |
$RX
BioSyent Inc. |
FAX Investments Inc.
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$194,750
+25,000 vol $7.79 each |
2,146,100 | |
Filed 2022-07-04 10:23 Tx date 2022-06-30 |
$RX
BioSyent Inc. |
Driscoll, Blair
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$194,750
+25,000 vol $7.79 each |
2,146,100 | |
Filed 2022-07-04 10:20 Tx date 2022-06-30 |
$RX
BioSyent Inc. |
FAX Capital Corp.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$194,750
+25,000 vol $7.79 each |
2,146,100 | |
Filed 2022-06-03 10:07 Tx date 2022-05-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,900 vol |
0 | |
Filed 2022-06-03 10:06 Tx date 2022-05-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,602
+200 vol $8.01 each |
1,900 | |
Filed 2022-06-03 10:06 Tx date 2022-05-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,617
+1,700 vol $8.01 each |
1,700 | |
Filed 2022-06-03 10:05 Tx date 2022-05-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-17,600 vol |
0 | |
Filed 2022-06-03 10:04 Tx date 2022-05-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$94,355
+11,300 vol $8.35 each |
17,600 | |
Filed 2022-06-03 10:04 Tx date 2022-05-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$52,605
+6,300 vol $8.35 each |
6,300 | |
Filed 2022-06-03 10:03 Tx date 2022-05-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,200 vol |
0 | |
Filed 2022-06-03 10:02 Tx date 2022-05-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$43,259
+5,200 vol $8.32 each |
5,200 | |
Filed 2022-04-10 11:12 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$33,096
+3,641 vol $9.09 each |
66,190 | |
Filed 2022-04-08 09:47 Tx date 2022-03-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-20,600 vol |
0 | |
Filed 2022-04-08 09:47 Tx date 2022-03-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,240
+400 vol $8.10 each |
226,100 | |
Filed 2022-04-08 09:45 Tx date 2022-03-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,650
+200 vol $8.25 each |
20,600 | |
Filed 2022-04-08 09:45 Tx date 2022-03-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,912
+600 vol $8.19 each |
20,400 | |
Filed 2022-04-08 09:44 Tx date 2022-03-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,437
+4,200 vol $8.20 each |
19,800 | |
Filed 2022-04-08 09:43 Tx date 2022-03-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$73,710,000
+900 vol $81,900 each |
15,600 | |
Filed 2022-04-08 09:42 Tx date 2022-03-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,920
+600 vol $8.20 each |
14,700 | |
Filed 2022-04-08 09:42 Tx date 2022-03-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$68,849
+8,400 vol $8.20 each |
14,100 | |
Filed 2022-04-08 09:41 Tx date 2022-03-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,200
+1,000 vol $8.20 each |
5,700 | |
Filed 2022-04-05 10:05 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$23,997
+2,640 vol $9.09 each |
15,605 | |
Filed 2022-04-04 11:25 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$138,004
+15,182 vol $9.09 each |
966,344 | |
Filed 2022-04-03 18:40 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+5,721 vol |
43,424 | |
Filed 2022-04-01 16:56 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$53,603
+5,897 vol $9.09 each |
44,864 | |
Filed 2022-04-01 11:58 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$33,096
+3,641 vol $9.09 each |
46,658 | |
Filed 2022-04-01 11:50 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$29,842
+3,283 vol $9.09 each |
14,512 | |
Filed 2022-04-01 11:35 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,292 vol |
170,284 | |
Filed 2022-04-01 11:16 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$25,997
+2,860 vol $9.09 each |
19,924 | |
Filed 2022-04-01 09:48 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,980 vol |
12,550 | |
Filed 2022-04-01 09:10 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,072 vol |
104,635 | |
Filed 2022-04-01 09:00 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-9,050
-1,000 vol $9.05 each |
17,064 | |
Filed 2022-03-31 13:16 Tx date 2022-03-29 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-9,050
-1,000 vol $9.05 each |
18,064 | |
Filed 2022-03-31 12:59 Tx date 2022-03-29 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-9,110.88
-999 vol $9.12 each |
7,760 | |
Filed 2022-03-31 12:56 Tx date 2022-03-29 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-8,118.01
-901 vol $9.01 each |
8,759 | |
Filed 2022-03-31 12:55 Tx date 2022-03-29 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-8,920
-1,000 vol $8.92 each |
9,660 | |
Filed 2022-03-31 12:54 Tx date 2022-03-29 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-15,651.59
-1,741 vol $8.99 each |
10,660 | |
Filed 2022-03-31 12:33 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,989
+1,166 vol $7.71 each |
12,965 | |
Filed 2022-03-29 17:30 Tx date 2022-03-24 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-19,910
-2,200 vol $9.05 each |
62,549 | |
Filed 2022-03-28 19:25 Tx date 2022-03-24 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,622.59
-5,193 vol $7.63 each |
11,229 | |
Filed 2022-03-25 16:41 Tx date 2022-03-22 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,475
-500 vol $8.95 each |
19,564 | |
Filed 2022-03-25 16:39 Tx date 2022-03-24 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,550
-500 vol $9.10 each |
19,064 | |
Filed 2022-03-24 15:03 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,688
+1,516 vol $7.71 each |
951,162 | |
Filed 2022-03-23 12:27 Tx date 2022-03-21 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,341.60
-607 vol $8.80 each |
16,422 | |
Filed 2022-03-23 10:29 Tx date 2022-03-18 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-68,697.51
-8,247 vol $8.33 each |
17,029 | |
Filed 2022-03-22 08:21 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$671.44
+88 vol $7.63 each |
103,563 | |
Filed 2022-03-21 17:35 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,682
+737 vol $7.71 each |
64,749 | |
Filed 2022-03-21 07:14 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,060
+270 vol $7.63 each |
10,580 | |
Filed 2022-03-16 15:08 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+858 vol |
37,703 | |
Filed 2022-03-15 18:33 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$17,270
+2,240 vol $7.71 each |
38,967 | |
Filed 2022-03-14 23:12 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,181
+672 vol $7.71 each |
25,276 | |
Filed 2022-03-14 11:40 Tx date 2021-12-13 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,317
+560 vol $7.71 each |
20,064 | |
Filed 2022-03-14 11:21 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,364
+1,474 vol $7.71 each |
43,017 | |
Filed 2022-03-10 10:48 Tx date 2022-02-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,622
+2,200 vol $8.01 each |
225,700 | |
Filed 2022-03-10 10:47 Tx date 2022-02-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,305
+4,700 vol $8.15 each |
4,700 | |
Filed 2022-03-10 10:46 Tx date 2022-02-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-6,600 vol |
0 | |
Filed 2022-03-10 10:45 Tx date 2022-02-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-64,900 vol |
6,600 | |
Filed 2022-03-10 10:44 Tx date 2022-02-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$52,932
+6,600 vol $8.02 each |
71,500 | |
Filed 2022-03-10 10:44 Tx date 2022-02-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$114,799
+14,000 vol $8.20 each |
64,900 | |
Filed 2022-03-10 10:42 Tx date 2022-02-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$84,530
+10,400 vol $8.13 each |
50,900 | |
Filed 2022-03-10 10:41 Tx date 2022-02-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,434
+3,000 vol $8.14 each |
40,500 | |
Filed 2022-03-10 10:41 Tx date 2022-02-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,966
+3,800 vol $8.15 each |
37,500 | |
Filed 2022-03-10 10:40 Tx date 2022-02-16 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,228
+1,400 vol $8.02 each |
33,700 | |
Filed 2022-03-10 10:39 Tx date 2022-02-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,005
+500 vol $8.01 each |
32,300 | |
Filed 2022-03-10 10:38 Tx date 2022-02-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$37,976
+4,700 vol $8.08 each |
31,800 | |
Filed 2022-03-10 10:38 Tx date 2022-02-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,179
+1,500 vol $8.12 each |
27,100 | |
Filed 2022-03-10 10:27 Tx date 2022-02-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,079
+3,100 vol $8.09 each |
25,600 | |
Filed 2022-03-10 10:27 Tx date 2022-02-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,250
+2,500 vol $8.10 each |
22,500 | |
Filed 2022-03-10 10:26 Tx date 2022-02-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$32,479
+4,000 vol $8.12 each |
20,000 | |
Filed 2022-03-10 10:25 Tx date 2022-02-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,000
+1,000 vol $8.00 each |
16,000 | |
Filed 2022-03-10 10:24 Tx date 2022-02-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,600
+1,200 vol $8.00 each |
15,000 | |
Filed 2022-02-10 10:21 Tx date 2022-01-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$55,927
+7,000 vol $7.99 each |
223,500 | |
Filed 2022-02-10 10:20 Tx date 2022-01-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$120,349
+15,000 vol $8.02 each |
216,500 | |
Filed 2022-02-01 15:13 Tx date 2022-01-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-32,700 vol |
13,800 | |
Filed 2022-02-01 15:12 Tx date 2022-01-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$797.00
+100 vol $7.97 each |
46,500 | |
Filed 2022-02-01 15:12 Tx date 2022-01-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,454
+1,700 vol $7.91 each |
46,400 | |
Filed 2022-02-01 15:11 Tx date 2022-01-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$70,415
+8,800 vol $8.00 each |
44,700 | |
Filed 2022-02-01 15:10 Tx date 2022-01-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,400
+2,300 vol $8.00 each |
35,900 | |
Filed 2022-02-01 15:08 Tx date 2022-01-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,200
+900 vol $8.00 each |
33,600 | |
Filed 2022-02-01 15:08 Tx date 2022-01-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$48,759
+6,100 vol $7.99 each |
32,700 | |
Filed 2022-02-01 15:06 Tx date 2022-01-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$805.00
+100 vol $8.05 each |
26,600 | |
Filed 2022-02-01 15:05 Tx date 2022-01-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,385
+4,500 vol $8.09 each |
26,500 | |
Filed 2022-02-01 15:04 Tx date 2022-01-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,069
+2,600 vol $8.10 each |
22,000 | |
Filed 2022-02-01 15:04 Tx date 2022-01-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,440
+2,400 vol $8.10 each |
19,400 | |
Filed 2022-02-01 15:03 Tx date 2022-01-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,900
+1,200 vol $8.25 each |
17,000 | |
Filed 2022-02-01 15:02 Tx date 2022-01-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,900
+1,200 vol $8.25 each |
15,800 | |
Filed 2022-02-01 15:01 Tx date 2022-01-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,620
+2,500 vol $8.25 each |
14,600 | |
Filed 2022-02-01 15:00 Tx date 2022-01-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,060
+3,000 vol $8.02 each |
12,100 | |
Filed 2022-02-01 14:59 Tx date 2022-01-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,174
+3,000 vol $8.06 each |
9,100 | |
Filed 2022-02-01 14:59 Tx date 2022-01-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,490
+2,900 vol $8.10 each |
6,100 | |
Filed 2022-02-01 14:58 Tx date 2022-01-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,764
+2,900 vol $8.19 each |
3,200 | |
Filed 2022-01-05 12:29 Tx date 2021-12-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,475
+300 vol $8.25 each |
300 | |
Filed 2022-01-05 12:29 Tx date 2021-12-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-39,000 vol |
0 | |
Filed 2022-01-05 12:28 Tx date 2021-12-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,220
+1,000 vol $8.22 each |
39,000 | |
Filed 2022-01-05 12:28 Tx date 2021-12-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$101,813
+12,400 vol $8.21 each |
38,000 | |
Filed 2022-01-05 12:27 Tx date 2021-12-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,940
+3,200 vol $8.11 each |
25,600 | |
Filed 2022-01-05 12:26 Tx date 2021-12-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$35,277
+4,200 vol $8.40 each |
22,400 | |
Filed 2022-01-05 12:25 Tx date 2021-12-16 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,700
+200 vol $8.50 each |
18,200 | |
Filed 2022-01-05 12:24 Tx date 2021-12-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,976
+1,800 vol $8.32 each |
18,000 | |
Filed 2022-01-05 12:23 Tx date 2021-12-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,520
+300 vol $8.40 each |
16,200 | |
Filed 2022-01-05 12:22 Tx date 2021-12-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,545
+2,700 vol $8.35 each |
15,900 | |
Filed 2022-01-05 12:21 Tx date 2021-12-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,020
+1,200 vol $8.35 each |
13,200 | |
Filed 2022-01-05 12:20 Tx date 2021-12-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,170
+500 vol $8.34 each |
12,000 | |
Filed 2022-01-05 12:20 Tx date 2021-12-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$46,687
+5,600 vol $8.34 each |
11,500 | |
Filed 2022-01-05 12:19 Tx date 2021-11-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,000
+1,000 vol $7.00 each |
5,300 | |
Filed 2021-12-01 11:53 Tx date 2021-11-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,009
+4,300 vol $8.37 each |
4,900 | |
Filed 2021-12-01 11:53 Tx date 2021-11-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,020
+600 vol $8.37 each |
600 | |
Filed 2021-12-01 11:52 Tx date 2021-11-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-6,450 vol |
0 | |
Filed 2021-12-01 11:50 Tx date 2021-11-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$350.00
+50 vol $7.00 each |
6,450 | |
Filed 2021-12-01 11:49 Tx date 2021-11-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,784
+400 vol $6.96 each |
6,400 | |
Filed 2021-12-01 11:48 Tx date 2021-11-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,872
+700 vol $6.96 each |
6,000 | |
Filed 2021-12-01 11:47 Tx date 2021-11-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,960
+1,000 vol $6.96 each |
5,300 | |
Filed 2021-11-10 11:43 Tx date 2021-10-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-55,500 vol |
4,300 | |
Filed 2021-11-10 11:42 Tx date 2021-10-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,264
+900 vol $6.96 each |
59,800 | |
Filed 2021-11-10 11:41 Tx date 2021-10-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,496
+1,400 vol $6.78 each |
58,900 | |
Filed 2021-11-10 11:40 Tx date 2021-10-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,700
+2,000 vol $6.85 each |
57,500 | |
Filed 2021-11-10 11:39 Tx date 2021-10-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,172
+2,500 vol $6.87 each |
55,500 | |
Filed 2021-11-10 11:38 Tx date 2021-10-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,620
+4,400 vol $6.96 each |
53,000 | |
Filed 2021-11-10 11:37 Tx date 2021-10-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,250
+2,500 vol $6.90 each |
48,600 | |
Filed 2021-11-10 11:36 Tx date 2021-10-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$40,695
+5,900 vol $6.90 each |
46,100 | |
Filed 2021-11-10 11:36 Tx date 2021-10-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,236
+900 vol $6.93 each |
40,200 | |
Filed 2021-11-10 11:35 Tx date 2021-10-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$158,716
+22,700 vol $6.99 each |
39,300 | |
Filed 2021-11-10 11:34 Tx date 2021-10-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,893
+700 vol $6.99 each |
16,600 | |
Filed 2021-11-10 11:33 Tx date 2021-10-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$37,077
+5,300 vol $7.00 each |
15,900 | |
Filed 2021-11-10 11:33 Tx date 2021-10-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,100
+4,300 vol $7.00 each |
10,600 | |
Filed 2021-11-10 11:32 Tx date 2021-10-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,200
+2,600 vol $7.00 each |
6,300 | |
Filed 2021-11-10 11:31 Tx date 2021-10-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,700
+2,100 vol $7.00 each |
3,700 | |
Filed 2021-11-10 11:31 Tx date 2021-10-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,800
+400 vol $7.00 each |
1,600 | |
Filed 2021-11-10 11:30 Tx date 2021-10-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,600
+800 vol $7.00 each |
1,200 | |
Filed 2021-11-10 11:29 Tx date 2021-10-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,800
+400 vol $7.00 each |
400 | |
Filed 2021-10-08 09:32 Tx date 2021-09-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,200 vol |
0 | |
Filed 2021-10-08 09:31 Tx date 2021-09-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,395
+5,200 vol $7.00 each |
5,200 | |
Filed 2021-09-10 08:37 Tx date 2021-08-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,317
+6,700 vol $7.51 each |
201,500 | |
Filed 2021-08-09 17:03 Tx date 2021-07-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,783
+3,300 vol $7.51 each |
194,800 | |
Filed 2021-08-09 17:02 Tx date 2021-07-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$76,600
+10,000 vol $7.66 each |
191,500 | |
Filed 2021-08-09 17:01 Tx date 2021-07-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$155,200
+20,000 vol $7.76 each |
181,500 | |
Filed 2021-07-08 13:53 Tx date 2021-06-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,985
+400 vol $7.46 each |
161,500 | |
Filed 2021-06-11 11:37 Tx date 2021-06-09 |
$RX
BioSyent Inc. |
Driscoll, Merrilyn Joy
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,121,100 | ||
Filed 2021-06-11 11:31 Tx date 2021-06-09 |
$RX
BioSyent Inc. |
Driscoll, Sean
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,121,100 | ||
Filed 2021-06-11 11:28 Tx date 2021-06-09 |
$RX
BioSyent Inc. |
Driscoll, Blair
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,121,100 | ||
Filed 2021-06-11 11:24 Tx date 2021-06-09 |
$RX
BioSyent Inc. |
Federated Capital Corp.
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,121,100 | ||
Filed 2021-06-11 11:18 Tx date 2021-06-09 |
$RX
BioSyent Inc. |
FAX Investments Inc.
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,121,100 | ||
Filed 2021-06-11 11:09 Tx date 2021-06-09 |
$RX
BioSyent Inc. |
FAX Capital Corp.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,121,100 | ||
Filed 2021-05-07 08:53 Tx date 2021-04-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,860
+3,900 vol $7.40 each |
161,100 | |
Filed 2021-04-09 09:19 Tx date 2021-03-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$186,250
+25,000 vol $7.45 each |
157,200 | |
Filed 2021-04-09 09:17 Tx date 2021-03-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-9,500 vol |
0 | |
Filed 2021-04-09 09:16 Tx date 2021-03-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-65,000 vol |
9,500 | |
Filed 2021-04-09 09:16 Tx date 2021-03-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$66,975
+9,500 vol $7.05 each |
74,500 | |
Filed 2021-04-09 09:15 Tx date 2021-03-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$458,250
+65,000 vol $7.05 each |
65,000 | |
Filed 2021-03-24 17:28 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$131,998
+18,082 vol $7.30 each |
949,646 | |
Filed 2021-03-24 17:26 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,357
+1,063 vol $5.04 each |
931,564 | |
Filed 2021-03-23 17:20 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$29,236
+4,005 vol $7.30 each |
24,604 | |
Filed 2021-03-23 13:51 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,224 vol |
103,475 | |
Filed 2021-03-23 12:28 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$20,301
+2,781 vol $7.30 each |
11,799 | |
Filed 2021-03-23 08:50 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$52,005
+7,124 vol $7.30 each |
36,727 | |
Filed 2021-03-22 10:19 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$32,083
+4,395 vol $7.30 each |
64,012 | |
Filed 2021-03-20 12:51 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,897 vol |
165,992 | |
Filed 2021-03-19 19:50 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$32,083
+4,395 vol $7.30 each |
41,543 | |
Filed 2021-03-19 18:27 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,260 vol |
10,570 | |
Filed 2021-03-19 17:30 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+6,825 vol |
36,845 | |
Filed 2021-03-19 16:44 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$24,360
+3,337 vol $7.30 each |
19,504 | |
Filed 2021-03-12 13:50 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,952
+412 vol $4.74 each |
9,018 | |
Filed 2021-03-12 06:46 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,615
+519 vol $5.04 each |
59,617 | |
Filed 2021-03-11 17:05 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,600
+516 vol $5.04 each |
37,148 | |
Filed 2021-03-11 14:48 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,607
+950 vol $4.85 each |
29,603 | |
Filed 2021-03-10 22:52 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,383
+473 vol $5.04 each |
20,599 | |
Filed 2021-03-10 22:46 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,383
+473 vol $5.04 each |
||
Filed 2021-03-10 17:12 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+601 vol |
30,020 | |
Filed 2021-03-10 16:13 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,980
+393 vol $5.04 each |
16,167 | |
Filed 2021-01-08 10:34 Tx date 2020-12-16 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,715
+800 vol $7.14 each |
132,200 | |
Filed 2021-01-08 10:33 Tx date 2020-12-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,140
+3,400 vol $7.10 each |
131,400 | |
Filed 2020-06-26 16:35 Tx date 2020-06-24 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,000 vol |
29,419 | |
Filed 2020-06-08 10:23 Tx date 2020-06-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-52,400 vol |
0 | |
Filed 2020-06-08 10:22 Tx date 2020-06-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,000 vol |
52,400 | |
Filed 2020-06-08 10:22 Tx date 2020-05-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$209,076
+52,400 vol $3.99 each |
53,400 | |
Filed 2020-06-08 10:21 Tx date 2020-05-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,990
+1,000 vol $3.99 each |
1,000 | |
Filed 2020-06-08 10:20 Tx date 2020-05-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-18,000 vol |
0 | |
Filed 2020-06-08 10:19 Tx date 2020-05-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-109,600 vol |
18,000 | |
Filed 2020-06-08 10:19 Tx date 2020-05-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$47,880
+12,000 vol $3.99 each |
127,600 | |
Filed 2020-06-08 10:18 Tx date 2020-05-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,940
+6,000 vol $3.99 each |
115,600 | |
Filed 2020-06-08 10:17 Tx date 2020-05-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$437,304
+109,600 vol $3.99 each |
109,600 | |
Filed 2020-06-08 10:16 Tx date 2020-05-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-9,500 vol |
0 | |
Filed 2020-05-08 09:30 Tx date 2020-05-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-67,000 vol |
9,500 | |
Filed 2020-05-08 09:30 Tx date 2020-04-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$798.00
+200 vol $3.99 each |
76,500 | |
Filed 2020-05-08 09:29 Tx date 2020-04-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$37,107
+9,300 vol $3.99 each |
76,300 | |
Filed 2020-05-08 09:28 Tx date 2020-04-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$267,330
+67,000 vol $3.99 each |
67,000 | |
Filed 2020-05-08 09:26 Tx date 2020-04-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,900 vol |
0 | |
Filed 2020-05-08 09:26 Tx date 2020-04-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,583
+700 vol $3.69 each |
2,900 | |
Filed 2020-05-08 09:25 Tx date 2020-04-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,118
+2,200 vol $3.69 each |
2,200 | |
Filed 2020-05-08 09:24 Tx date 2020-04-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-36,000 vol |
0 | |
Filed 2020-05-08 09:23 Tx date 2020-04-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,210
+9,000 vol $3.69 each |
36,000 | |
Filed 2020-05-08 09:22 Tx date 2020-04-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,210
+9,000 vol $3.69 each |
27,000 | |
Filed 2020-05-08 09:22 Tx date 2020-04-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-36,000 vol |
18,000 | |
Filed 2020-05-08 09:21 Tx date 2020-04-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,210
+9,000 vol $3.69 each |
54,000 | |
Filed 2020-05-08 09:20 Tx date 2020-04-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,210
+9,000 vol $3.69 each |
45,000 | |
Filed 2020-05-08 09:19 Tx date 2020-04-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,210
+9,000 vol $3.69 each |
36,000 | |
Filed 2020-05-08 09:19 Tx date 2020-04-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,210
+9,000 vol $3.69 each |
27,000 | |
Filed 2020-05-08 09:18 Tx date 2020-04-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,210
+9,000 vol $3.69 each |
18,000 | |
Filed 2020-05-08 09:17 Tx date 2020-04-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$32,987
+9,000 vol $3.67 each |
149,175 | |
Filed 2020-04-06 15:18 Tx date 2020-03-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$216,000
+60,000 vol $3.60 each |
128,000 | |
Filed 2020-04-06 15:17 Tx date 2020-03-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$71,994
+20,000 vol $3.60 each |
68,000 | |
Filed 2020-04-06 15:15 Tx date 2020-03-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$71,432
+20,000 vol $3.57 each |
48,000 | |
Filed 2020-04-06 15:14 Tx date 2020-03-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$57,745
+16,000 vol $3.61 each |
28,000 | |
Filed 2020-04-06 15:13 Tx date 2020-03-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$42,723
+12,000 vol $3.56 each |
12,000 | |
Filed 2020-04-06 15:10 Tx date 2018-12-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-04-06 15:00 Tx date 2020-04-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-140,175 vol |
0 | |
Filed 2020-04-06 14:59 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$291,628
+80,175 vol $3.64 each |
140,175 | |
Filed 2020-04-06 14:58 Tx date 2020-03-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$216,000
+60,000 vol $3.60 each |
60,000 | |
Filed 2020-04-06 14:57 Tx date 2020-03-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-34,000 vol |
0 | |
Filed 2020-04-06 14:56 Tx date 2020-03-02 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$173,060
+34,000 vol $5.09 each |
34,000 | |
Filed 2020-04-05 22:05 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+6,981 vol |
20,126 | |
Filed 2020-04-05 09:34 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$29,999
+8,310 vol $3.61 each |
10,310 | |
Filed 2020-04-03 10:27 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+11,891 vol |
28,419 | |
Filed 2020-04-03 08:45 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+12,408 vol |
28,653 | |
Filed 2020-04-03 08:34 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$27,648
+7,659 vol $3.61 each |
59,098 | |
Filed 2020-04-02 12:58 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$113,751
+31,510 vol $3.61 each |
930,501 | |
Filed 2020-04-02 12:30 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$20,999
+5,817 vol $3.61 each |
15,774 | |
Filed 2020-04-02 12:23 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$27,648
+7,659 vol $3.61 each |
36,632 | |
Filed 2020-04-02 11:39 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$17,501
+4,848 vol $3.61 each |
8,606 | |
Filed 2020-04-01 10:17 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$29,999
+8,310 vol $3.61 each |
8,310 | |
Filed 2020-04-01 10:13 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-04-01 09:55 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+9,003 vol |
161,095 | |
Filed 2020-04-01 09:49 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+2,251 vol |
102,251 | |
Filed 2020-03-31 18:26 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,400
+4,000 vol $3.60 each |
898,991 | |
Filed 2020-03-31 18:21 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,495
+2,114 vol $7.33 each |
894,991 | |
Filed 2020-03-31 15:52 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,697
+640 vol $7.34 each |
3,758 | |
Filed 2020-03-31 15:48 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,118 | ||
Filed 2020-03-31 12:17 Tx date 2020-03-30 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,400
+4,000 vol $3.60 each |
16,528 | |
Filed 2020-03-31 11:43 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,696
+1,050 vol $7.33 each |
51,439 | |
Filed 2020-03-24 11:19 Tx date 2020-03-23 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$63,525
+18,150 vol $3.50 each |
28,973 | |
Filed 2020-03-23 09:39 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$39,250
+4,775 vol $8.22 each |
10,649 | |
Filed 2020-03-23 09:31 Tx date 2020-03-20 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,925
+2,500 vol $3.57 each |
16,245 | |
Filed 2019-03-22 15:21 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$39,250
+4,775 vol $8.22 each |
||
Filed 2020-03-13 14:17 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,188
+1,278 vol $7.19 each |
13,145 | |
Filed 2020-03-02 12:47 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,860
+1,037 vol $7.58 each |
12,528 | |
Filed 2020-03-02 10:53 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,501
+1,022 vol $7.34 each |
10,823 | |
Filed 2020-03-02 10:14 Tx date 2020-01-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,422
+1,552 vol $7.36 each |
18,520 | |
Filed 2020-03-02 08:42 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,746
+784 vol $7.33 each |
9,957 | |
Filed 2020-02-10 10:54 Tx date 2020-01-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-38,300 vol |
0 | |
Filed 2020-02-10 10:54 Tx date 2020-01-21 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$229,800
+38,300 vol $6.00 each |
38,300 | |
Filed 2020-02-10 10:52 Tx date 2020-01-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,000 vol |
0 | |
Filed 2020-02-10 10:52 Tx date 2020-01-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,800
+3,300 vol $6.00 each |
5,000 | |
Filed 2020-02-10 10:51 Tx date 2020-01-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,200
+1,700 vol $6.00 each |
1,700 | |
Filed 2020-01-10 10:23 Tx date 2020-01-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-30,000 vol |
0 | |
Filed 2020-01-10 10:22 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$29,750
+5,000 vol $5.95 each |
30,000 | |
Filed 2020-01-10 10:21 Tx date 2019-12-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$123,499
+20,600 vol $6.00 each |
25,000 | |
Filed 2020-01-10 10:20 Tx date 2019-12-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$26,400
+4,400 vol $6.00 each |
4,400 | |
Filed 2020-01-10 10:19 Tx date 2019-12-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-21,000 vol |
0 | |
Filed 2020-01-10 10:18 Tx date 2019-12-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,980
+1,000 vol $5.98 each |
21,000 | |
Filed 2020-01-10 10:17 Tx date 2019-12-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$120,000
+20,000 vol $6.00 each |
20,000 | |
Filed 2019-12-24 18:41 Tx date 2002-06-25 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: AQUIAM (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
Filed 2019-12-22 09:13 Tx date 2019-12-18 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+200 vol |
11,491 | |
Filed 2019-11-08 15:49 Tx date 2019-10-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-47,177 vol |
0 | |
Filed 2019-11-08 15:49 Tx date 2019-10-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$291,406
+47,077 vol $6.19 each |
47,177 | |
Filed 2019-11-08 15:48 Tx date 2019-10-15 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-17,323 vol |
100 | |
Filed 2019-11-08 15:47 Tx date 2019-10-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$619.00
+100 vol $6.19 each |
17,423 | |
Filed 2019-11-08 15:47 Tx date 2019-10-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,400
+400 vol $6.00 each |
17,323 | |
Filed 2019-11-08 15:46 Tx date 2019-10-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-23,500 vol |
16,923 | |
Filed 2019-11-08 15:45 Tx date 2019-10-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,230
+16,923 vol $6.10 each |
40,423 | |
Filed 2019-11-08 15:44 Tx date 2019-10-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,600
+2,600 vol $6.00 each |
23,500 | |
Filed 2019-10-10 13:39 Tx date 2019-09-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-47,500 vol |
20,900 | |
Filed 2019-10-10 13:38 Tx date 2019-09-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$54,000
+9,000 vol $6.00 each |
68,400 | |
Filed 2019-10-10 13:36 Tx date 2019-09-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,200
+200 vol $6.00 each |
59,400 | |
Filed 2019-10-10 13:36 Tx date 2019-09-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$69,523
+11,600 vol $5.99 each |
59,200 | |
Filed 2019-10-10 13:35 Tx date 2019-09-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$595.00
+100 vol $5.95 each |
47,600 | |
Filed 2019-10-10 13:34 Tx date 2019-09-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$54,701
+9,100 vol $6.01 each |
47,500 | |
Filed 2019-10-10 13:34 Tx date 2019-09-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-55,900 vol |
38,400 | |
Filed 2019-10-10 13:33 Tx date 2019-09-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$89,528
+14,800 vol $6.05 each |
94,300 | |
Filed 2019-10-10 13:32 Tx date 2019-09-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$75,726
+12,600 vol $6.01 each |
79,500 | |
Filed 2019-10-10 13:31 Tx date 2019-09-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$66,155
+11,000 vol $6.01 each |
66,900 | |
Filed 2019-10-10 13:30 Tx date 2019-09-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$40,267
+6,700 vol $6.01 each |
55,900 | |
Filed 2019-10-10 13:26 Tx date 2019-09-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$204,076
+32,600 vol $6.26 each |
49,200 | |
Filed 2019-10-10 13:25 Tx date 2019-09-16 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$85,956
+13,800 vol $6.23 each |
16,600 | |
Filed 2019-10-10 13:21 Tx date 2019-09-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,845
+300 vol $6.15 each |
2,800 | |
Filed 2019-10-10 13:21 Tx date 2019-09-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,500 vol |
2,500 | |
Filed 2019-10-10 13:20 Tx date 2019-09-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,594
+600 vol $5.99 each |
5,000 | |
Filed 2019-10-10 13:19 Tx date 2019-09-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-7,400 vol |
4,400 | |
Filed 2019-10-10 13:17 Tx date 2019-09-06 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,785
+300 vol $5.95 each |
11,800 | |
Filed 2019-10-10 13:17 Tx date 2019-09-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,440
+1,600 vol $5.90 each |
11,500 | |
Filed 2019-10-10 13:16 Tx date 2019-09-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,630
+2,500 vol $5.85 each |
9,900 | |
Filed 2019-10-10 13:15 Tx date 2019-09-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,645
+3,700 vol $5.85 each |
7,400 | |
Filed 2019-09-10 09:50 Tx date 2019-08-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,805
+2,200 vol $5.82 each |
3,700 | |
Filed 2019-09-10 09:49 Tx date 2019-08-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-31,932 vol |
1,500 | |
Filed 2019-09-10 09:48 Tx date 2019-08-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,700
+1,500 vol $5.80 each |
33,432 | |
Filed 2019-09-10 09:47 Tx date 2019-08-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,509
+432 vol $5.81 each |
31,932 | |
Filed 2019-09-10 09:46 Tx date 2019-08-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,742
+5,800 vol $5.99 each |
31,500 | |
Filed 2019-09-10 09:45 Tx date 2019-08-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,032
+5,100 vol $5.89 each |
25,700 | |
Filed 2019-09-10 09:43 Tx date 2019-08-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-700 vol |
20,600 | |
Filed 2019-09-10 09:42 Tx date 2019-08-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$118,392
+20,600 vol $5.75 each |
21,300 | |
Filed 2019-09-10 09:41 Tx date 2019-08-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-800 vol |
700 | |
Filed 2019-09-10 09:40 Tx date 2019-08-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,774
+600 vol $6.29 each |
1,500 | |
Filed 2019-09-10 09:39 Tx date 2019-08-16 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$629.00
+100 vol $6.29 each |
900 | |
Filed 2019-09-10 09:38 Tx date 2019-08-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,024
+800 vol $6.28 each |
800 | |
Filed 2019-08-09 10:21 Tx date 2019-07-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-4,500 vol |
0 | |
Filed 2019-08-09 10:20 Tx date 2019-07-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,305
+4,500 vol $6.29 each |
4,500 | |
Filed 2019-07-10 09:50 Tx date 2019-07-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-15,000 vol |
0 | |
Filed 2019-07-10 09:49 Tx date 2019-06-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$97,500
+15,000 vol $6.50 each |
15,000 | |
Filed 2019-07-10 09:46 Tx date 2019-06-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-262,100 vol |
0 | |
Filed 2019-07-10 09:45 Tx date 2019-06-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,884,499
+262,100 vol $7.19 each |
262,100 | |
Filed 2019-06-24 16:14 Tx date 2019-06-24 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,980
+300 vol $6.60 each |
14,100 | |
Filed 2019-06-17 17:47 Tx date 2019-06-17 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+200 vol $6.75 each |
13,800 | |
Filed 2019-06-07 10:10 Tx date 2019-05-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-9,200 vol |
0 | |
Filed 2019-06-07 10:09 Tx date 2019-05-13 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,250
+1,500 vol $7.50 each |
9,200 | |
Filed 2019-06-07 10:09 Tx date 2019-05-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-11,700 vol |
7,700 | |
Filed 2019-06-07 10:07 Tx date 2019-05-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,500
+600 vol $7.50 each |
19,400 | |
Filed 2019-06-07 10:06 Tx date 2019-05-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$53,250
+7,100 vol $7.50 each |
18,800 | |
Filed 2019-06-07 10:06 Tx date 2019-05-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$42,000
+5,600 vol $7.50 each |
11,700 | |
Filed 2019-06-07 10:05 Tx date 2019-05-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,250
+5,100 vol $7.50 each |
6,100 | |
Filed 2019-06-07 10:04 Tx date 2019-05-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,400
+1,000 vol $7.40 each |
46,800 | |
Filed 2019-06-03 17:21 Tx date 2019-06-03 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+400 vol $6.75 each |
13,600 | |
Filed 2019-05-14 10:24 Tx date 2019-04-26 |
$RX
BioSyent Inc. |
D'Souza, Alfred
4 - Director of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-300,000
-40,000 vol $7.50 each |
1,386,300 | |
Filed 2019-05-10 09:49 Tx date 2019-05-03 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-45,800 vol |
0 | |
Filed 2019-05-10 09:48 Tx date 2019-04-30 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,100
+1,500 vol $7.40 each |
45,800 | |
Filed 2019-05-10 09:47 Tx date 2019-04-29 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,680
+3,200 vol $7.40 each |
44,300 | |
Filed 2019-05-10 09:45 Tx date 2019-04-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$300,000
+40,000 vol $7.50 each |
41,100 | |
Filed 2019-05-10 09:44 Tx date 2019-04-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-51,000 vol |
1,100 | |
Filed 2019-05-10 09:42 Tx date 2019-04-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,195
+1,100 vol $7.45 each |
52,100 | |
Filed 2019-05-10 09:41 Tx date 2019-04-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$190,686
+25,500 vol $7.48 each |
51,000 | |
Filed 2019-05-10 09:40 Tx date 2019-04-23 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$185,504
+24,800 vol $7.48 each |
25,500 | |
Filed 2019-05-10 09:39 Tx date 2019-04-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,900 vol |
700 | |
Filed 2019-05-10 09:37 Tx date 2019-04-16 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,236
+700 vol $7.48 each |
3,600 | |
Filed 2019-05-10 09:36 Tx date 2019-04-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,750
+500 vol $7.50 each |
2,900 | |
Filed 2019-05-10 09:35 Tx date 2019-04-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,496
+200 vol $7.48 each |
2,400 | |
Filed 2019-05-10 09:35 Tx date 2019-04-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,410
+1,800 vol $7.45 each |
2,200 | |
Filed 2019-05-10 09:33 Tx date 2019-04-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,980
+400 vol $7.45 each |
400 | |
Filed 2019-04-10 10:09 Tx date 2019-04-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-50,000 vol |
0 | |
Filed 2019-04-10 10:07 Tx date 2019-04-01 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-115,200 vol |
50,000 | |
Filed 2019-04-10 10:06 Tx date 2019-03-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$186,250
+25,000 vol $7.45 each |
165,200 | |
Filed 2019-04-10 10:03 Tx date 2019-03-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$187,500
+25,000 vol $7.50 each |
140,200 | |
Filed 2019-04-10 10:02 Tx date 2019-03-26 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$184,500
+24,600 vol $7.50 each |
115,200 | |
Filed 2019-04-10 10:01 Tx date 2019-03-25 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$298,302
+40,500 vol $7.37 each |
90,600 | |
Filed 2019-04-10 09:59 Tx date 2019-03-22 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$400,000
+50,000 vol $8.00 each |
50,100 | |
Filed 2019-04-10 09:57 Tx date 2019-02-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$800.00
+100 vol $8.00 each |
100 | |
Filed 2019-03-28 Tx date 2019-03-25 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,340
+1,000 vol $7.34 each |
||
Filed 2019-03-28 Tx date 2019-03-25 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,680
+2,000 vol $7.34 each |
2,000 | |
Filed 2019-03-28 Tx date 2018-09-04 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-03-28 Tx date 2019-03-28 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$90,021
+11,955 vol $7.53 each |
16,968 | |
Filed 2019-03-28 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-03-28 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-03-28 Tx date 2019-03-28 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$85,021
+11,291 vol $7.53 each |
11,291 | |
Filed 2019-03-28 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$15,371
+1,870 vol $8.22 each |
1,870 | |
Filed 2019-03-27 Tx date 2018-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,000
+1,574 vol $9.53 each |
892,877 | |
Filed 2019-03-24 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$98,113
+11,936 vol $8.22 each |
334,345 | |
Filed 2019-03-24 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$25,186
+3,064 vol $8.22 each |
19,951 | |
Filed 2019-03-22 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$24,528
+2,984 vol $8.22 each |
15,184 | |
Filed 2019-03-22 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$18,807
+2,288 vol $8.22 each |
9,173 | |
Filed 2019-03-22 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$39,250
+4,775 vol $8.22 each |
5,013 | |
Filed 2019-03-22 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$22,892
+2,785 vol $8.22 each |
12,401 | |
Filed 2019-03-22 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$37,063
+4,509 vol $8.22 each |
9,948 | |
Filed 2019-03-11 Tx date 2018-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,602
+586 vol $9.56 each |
6,885 | |
Filed 2019-03-08 Tx date 2019-02-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,200
+1,900 vol $8.00 each |
1,900 | |
Filed 2019-03-08 Tx date 2019-02-08 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
Filed 2019-03-08 Tx date 2019-02-05 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,200
+3,400 vol $8.00 each |
5,300 | |
Filed 2019-03-07 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-03-07 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
238 | ||
Filed 2019-03-06 Tx date 2019-03-05 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,500
+787 vol $9.53 each |
50,389 | |
Filed 2019-03-04 Tx date 2018-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,945
+1,780 vol $9.52 each |
11,867 | |
Filed 2019-03-04 Tx date 2018-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,147
+750 vol $9.53 each |
9,801 | |
Filed 2019-02-08 Tx date 2019-01-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-23,800 vol |
0 | |
Filed 2019-02-08 Tx date 2019-01-07 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$212,440
+26,600 vol $7.99 each |
26,600 | |
Filed 2019-02-08 Tx date 2019-01-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-20,068 vol |
0 | |
Filed 2019-02-08 Tx date 2019-01-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-26,600 vol |
23,800 | |
Filed 2019-02-08 Tx date 2019-01-09 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$190,400
+23,800 vol $8.00 each |
50,400 | |
Filed 2019-02-03 Tx date 2019-01-30 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-190,021
-23,500 vol $8.09 each |
1,426,300 | |
Filed 2019-01-21 Tx date 2019-01-15 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-212,000
-26,500 vol $8.00 each |
1,449,800 | |
Filed 2019-01-03 Tx date 2018-12-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-14,500 vol |
20,068 | |
Filed 2019-01-03 Tx date 2018-12-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-57,600 vol |
16,200 | |
Filed 2019-01-03 Tx date 2018-12-24 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,260
+1,700 vol $7.80 each |
73,800 | |
Filed 2019-01-03 Tx date 2018-12-10 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-03 Tx date 2018-12-28 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,400
+3,800 vol $8.00 each |
20,100 | |
Filed 2019-01-03 Tx date 2018-12-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,166
+3,400 vol $7.99 each |
57,600 | |
Filed 2019-01-03 Tx date 2018-12-27 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$780.00
+100 vol $7.80 each |
16,300 | |
Filed 2019-01-03 Tx date 2018-12-14 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$433,594
+54,200 vol $8.00 each |
54,200 | |
Filed 2019-01-03 Tx date 2018-12-19 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$44,800
+5,600 vol $8.00 each |
63,200 | |
Filed 2019-01-03 Tx date 2018-12-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$115,744
+14,468 vol $8.00 each |
34,568 | |
Filed 2019-01-03 Tx date 2018-12-20 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$71,200
+8,900 vol $8.00 each |
72,100 | |
Filed 2018-12-21 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$37,268
+8,375 vol $4.45 each |
330,784 | |
Filed 2018-12-21 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
10 - Acquisition or disposition in the public market
|
$-64,545
-8,275 vol $7.80 each |
322,509 | |
Filed 2018-12-21 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
10 - Acquisition or disposition in the public market
|
$-781.00
-100 vol $7.81 each |
322,409 | |
Filed 2018-12-14 Tx date 2018-12-14 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,000
-500 vol $8.00 each |
152,092 | |
Filed 2018-12-14 Tx date 2018-12-14 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Carson RESP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,600
-2,700 vol $8.00 each |
0 | |
Filed 2018-12-14 Tx date 2018-12-14 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,800
-600 vol $8.00 each |
0 | |
Filed 2018-11-15 Tx date 2018-11-12 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-12,985
-1,400 vol $9.28 each |
1,476,300 | |
Filed 2018-11-03 Tx date 2018-11-02 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-130,690
-14,000 vol $9.34 each |
1,477,700 | |
Filed 2018-11-03 Tx date 2018-10-29 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,545
-700 vol $9.35 each |
1,491,700 | |
Filed 2018-10-04 Tx date 2018-10-01 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-9,705.60
-1,011 vol $9.60 each |
||
Filed 2018-10-04 Tx date 2018-09-27 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-9,705.60
-1,011 vol $9.60 each |
||
Filed 2018-10-04 Tx date 2018-09-27 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$6,901
+1,551 vol $4.45 each |
16,887 | |
Filed 2018-10-04 Tx date 2018-09-27 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,705.60
-1,011 vol $9.60 each |
49,602 | |
Filed 2018-10-02 Tx date 2018-10-01 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-9,705.60
-1,011 vol $9.60 each |
49,602 | |
Filed 2018-09-19 Tx date 2018-09-07 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-133,700
-14,000 vol $9.55 each |
1,492,400 | |
Filed 2018-09-13 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
5,874 | ||
Filed 2018-09-12 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-392,179.20
-40,852 vol $9.60 each |
927,303 | |
Filed 2018-09-12 Tx date 2018-09-12 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-345,600
-36,000 vol $9.60 each |
891,303 | |
Filed 2018-09-12 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,825
-500 vol $9.65 each |
968,155 | |
Filed 2018-09-12 Tx date 2018-09-07 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-169,035
-17,700 vol $9.55 each |
968,655 | |
Filed 2018-09-11 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$52,214
+5,439 vol $9.60 each |
5,439 | |
Filed 2018-09-11 Tx date 2018-09-04 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-09-01 Tx date 2018-08-27 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-462,500
-50,000 vol $9.25 each |
1,506,400 | |
Filed 2018-07-01 Tx date 2018-06-29 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,636
-700 vol $9.48 each |
1,556,400 | |
Filed 2018-07-01 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-95,000
-10,000 vol $9.50 each |
1,557,100 | |
Filed 2018-06-27 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,137
-2,646 vol $9.50 each |
1,407 | |
Filed 2018-06-27 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,035
+4,053 vol $4.45 each |
4,053 | |
Filed 2018-06-27 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,261
+1,407 vol $4.45 each |
||
Filed 2018-06-26 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-18,035.85
-4,053 vol $4.45 each |
4,165 | |
Filed 2018-06-26 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,261
+1,407 vol $4.45 each |
1,407 | |
Filed 2018-06-26 Tx date 2014-01-15 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-06-19 Tx date 2018-06-13 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-14,685
-3,300 vol $4.45 each |
14,627 | |
Filed 2018-06-19 Tx date 2018-06-18 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-982.00
-100 vol $9.82 each |
1,567,100 | |
Filed 2018-06-19 Tx date 2018-06-15 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,745
-1,700 vol $9.85 each |
1,567,200 | |
Filed 2018-06-19 Tx date 2018-06-13 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,610
-3,000 vol $9.87 each |
1,568,900 | |
Filed 2018-06-19 Tx date 2018-06-13 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-33,000
-3,300 vol $10.00 each |
2,371 | |
Filed 2018-06-19 Tx date 2018-06-13 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$14,685
+3,300 vol $4.45 each |
5,671 | |
Filed 2018-06-12 Tx date 2018-06-08 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,060
-2,000 vol $10.03 each |
1,571,900 | |
Filed 2018-06-12 Tx date 2018-06-06 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,105
-2,100 vol $10.05 each |
1,573,900 | |
Filed 2018-06-01 Tx date 2003-10-21 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-06-01 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$10,905
+1,136 vol $9.60 each |
1,136 | |
Filed 2018-06-01 Tx date 2018-05-29 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$31,012
+3,120 vol $9.94 each |
4,256 | |
Filed 2018-06-01 Tx date 2018-06-01 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,920
+400 vol $9.80 each |
152,592 | |
Filed 2018-03-28 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,495
+1,841 vol $8.96 each |
10,087 | |
Filed 2018-03-28 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$21,244
+2,371 vol $8.96 each |
2,371 | |
Filed 2018-03-27 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,096
+792 vol $8.96 each |
50,613 | |
Filed 2018-03-27 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,995
+1,562 vol $8.96 each |
986,355 | |
Filed 2018-03-26 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,001
+302 vol $9.94 each |
6,299 | |
Filed 2018-03-26 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,648
+742 vol $8.96 each |
9,051 | |
Filed 2018-01-15 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$38,419
+4,002 vol $9.60 each |
17,927 | |
Filed 2018-01-12 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$93,456
+9,735 vol $9.60 each |
322,409 | |
Filed 2018-01-12 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$21,100
+2,198 vol $9.60 each |
9,616 | |
Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$24,921
+2,596 vol $9.60 each |
8,517 | |
Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$17,443
+1,817 vol $9.60 each |
5,702 | |
Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$22,272
+2,320 vol $9.60 each |
12,200 | |
Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$31,152
+3,245 vol $9.60 each |
3,245 | |
Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-09 Tx date 2018-01-09 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$23,366
+2,434 vol $9.60 each |
15,336 | |
Filed 2018-01-09 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$10,905
+1,136 vol $9.60 each |
49,058 | |
Filed 2018-01-09 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
3,245 | ||
Filed 2018-01-09 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
13,200 | ||
Filed 2018-01-09 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$10,905
+1,136 vol $9.60 each |
8,218 | |
Filed 2018-01-08 Tx date 1996-06-07 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
Filed 2018-01-08 Tx date 1996-07-25 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-08 Tx date 1996-07-25 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-08 Tx date 1996-06-07 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
65,000 | ||
Filed 2018-01-08 Tx date 1996-06-07 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
Filed 2018-01-08 Tx date 1996-07-25 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-08 Tx date 1996-06-07 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Warrants
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2018-01-08 Tx date 1996-07-25 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-12-23 Tx date 2017-12-18 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$8,918
+9,800 vol $0.91 each |
312,674 | |
Filed 2017-12-23 Tx date 2017-12-18 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$96,725
+9,800 vol $9.87 each |
984,793 | |
Filed 2017-12-18 Tx date 2017-12-15 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-14,076.70
-1,474 vol $9.55 each |
49,821 | |
Filed 2017-12-05 Tx date 2017-12-05 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,100
-500 vol $10.20 each |
600 | |
Filed 2017-12-04 Tx date 2017-12-01 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,400
-800 vol $10.50 each |
277,900 | |
Filed 2017-12-04 Tx date 2017-12-04 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,150
-500 vol $10.30 each |
1,100 | |
Filed 2017-12-04 Tx date 2017-12-04 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,150
-500 vol $10.30 each |
1,600 | |
Filed 2017-11-24 Tx date 2017-11-24 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,125
-500 vol $10.25 each |
2,100 | |
Filed 2017-11-23 Tx date 2017-11-20 |
$RX
BioSyent Inc. |
Montador, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$3,549
+3,900 vol $0.91 each |
11,822 | |
Filed 2017-11-23 Tx date 2017-11-20 |
$RX
BioSyent Inc. |
Montador, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$39,780
+3,900 vol $10.20 each |
78,900 | |
Filed 2017-11-23 Tx date 2017-11-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,100
-500 vol $10.20 each |
2,600 | |
Filed 2017-09-26 Tx date 2017-09-21 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$5,551
+6,100 vol $0.91 each |
1,582,100 | |
Filed 2017-09-26 Tx date 2017-09-21 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-5,551
-6,100 vol $0.91 each |
13,925 | |
Filed 2017-09-26 Tx date 2017-09-22 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-55,510
-6,100 vol $9.10 each |
1,576,000 | |
Filed 2017-09-19 Tx date 2017-09-18 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,418
+993 vol $4.45 each |
121,569 | |
Filed 2017-09-19 Tx date 2017-09-18 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
52 - Expiration of options
|
$7,613
+1,228 vol $6.20 each |
122,797 | |
Filed 2017-09-18 Tx date 2017-09-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,025
-1,300 vol $9.25 each |
16,621 | |
Filed 2017-09-18 Tx date 2017-09-18 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,170
-6,000 vol $9.20 each |
86,100 | |
Filed 2017-09-15 Tx date 2017-09-15 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,850
-200 vol $9.25 each |
17,921 | |
Filed 2017-09-15 Tx date 2017-09-14 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,800
-1,500 vol $9.20 each |
18,121 | |
Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$8,937
+993 vol $9.00 each |
||
Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$8,937
+993 vol $9.00 each |
18,393 | |
Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$11,052
+1,228 vol $9.00 each |
19,621 | |
Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$11,052
+1,228 vol $9.00 each |
||
Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$11,052
+1,228 vol $9.00 each |
||
Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$8,937
+993 vol $9.00 each |
||
Filed 2017-08-18 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,418
+993 vol $4.45 each |
369 | |
Filed 2017-08-18 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$11,052
+1,228 vol $9.00 each |
3,818 | |
Filed 2017-08-18 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$7,613
+1,228 vol $6.20 each |
2,590 | |
Filed 2017-08-18 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$8,937
+993 vol $9.00 each |
1,362 | |
Filed 2017-08-17 Tx date 2017-08-14 |
$RX
BioSyent Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
5,921 | ||
Filed 2017-07-05 Tx date 2015-01-12 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-07-05 Tx date 2017-07-04 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$65,994
+8,246 vol $8.00 each |
8,246 | |
Filed 2017-07-05 Tx date 2017-07-04 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$70,996
+8,871 vol $8.00 each |
51,295 | |
Filed 2017-07-04 Tx date 2017-07-04 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$66,498
+8,309 vol $8.00 each |
8,309 | |
Filed 2017-07-04 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-07-04 Tx date 2017-07-04 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$47,995
+5,997 vol $8.00 each |
5,997 | |
Filed 2017-07-04 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-07-04 Tx date 2017-07-04 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$139,944
+17,493 vol $8.00 each |
974,993 | |
Filed 2017-06-21 Tx date 2017-06-21 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,830
-600 vol $8.05 each |
279,700 | |
Filed 2017-06-21 Tx date 2017-06-21 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,100
-1,000 vol $8.10 each |
278,700 | |
Filed 2017-06-20 Tx date 2017-06-19 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-805.00
-100 vol $8.05 each |
280,300 | |
Filed 2017-06-16 Tx date 2017-06-16 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,980
-1,000 vol $7.98 each |
92,100 | |
Filed 2017-06-14 Tx date 2017-06-12 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,610
-200 vol $8.05 each |
280,400 | |
Filed 2017-06-13 Tx date 2017-06-13 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,840
-2,000 vol $7.92 each |
93,100 | |
Filed 2017-06-08 Tx date 2017-06-08 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,860
-2,000 vol $7.93 each |
95,100 | |
Filed 2017-06-06 Tx date 2017-06-06 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,480
-2,000 vol $7.74 each |
97,100 | |
Filed 2017-06-03 Tx date 2017-06-01 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$3,549
+3,900 vol $0.91 each |
101,100 | |
Filed 2017-06-03 Tx date 2017-06-01 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$3,549
+3,900 vol $0.91 each |
120,576 | |
Filed 2017-06-02 Tx date 2017-06-02 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,600
-2,000 vol $7.80 each |
95,200 | |
Filed 2017-04-04 Tx date 2014-06-13 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
+882 vol |
81,533 | |
Filed 2017-04-04 Tx date 2014-06-12 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80,500
-10,000 vol $8.05 each |
15,000 | |
Filed 2017-04-04 Tx date 2017-03-31 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,950
-1,800 vol $7.75 each |
1,576,000 | |
Filed 2017-04-04 Tx date 2017-03-31 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,950
-1,800 vol $7.75 each |
||
Filed 2017-04-04 Tx date 2014-08-28 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-93,000
-10,000 vol $9.30 each |
0 | |
Filed 2017-04-04 Tx date 2017-03-30 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,000
-5,000 vol $7.60 each |
1,577,800 | |
Filed 2017-04-04 Tx date 2016-12-12 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-790.00
-100 vol $7.90 each |
0 | |
Filed 2017-04-04 Tx date 2014-06-16 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,500
-5,000 vol $7.50 each |
10,000 | |
Filed 2017-04-03 Tx date 2016-09-29 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
59 - Exercise for cash
|
$-83,853
-9,900 vol $8.47 each |
||
Filed 2017-04-03 Tx date 2016-09-29 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-83,853
-9,900 vol $8.47 each |
25,100 | |
Filed 2017-04-03 Tx date 2016-09-29 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$83,853
+9,900 vol $8.47 each |
||
Filed 2017-04-03 Tx date 2016-09-29 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$83,853
+9,900 vol $8.47 each |
||
Filed 2017-04-03 Tx date 2016-09-29 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
59 - Exercise for cash
|
$-83,853
-9,900 vol $8.47 each |
||
Filed 2017-03-31 Tx date 2017-03-31 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,975
-900 vol $7.75 each |
280,600 | |
Filed 2017-03-30 Tx date 2017-03-23 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$468,650
+65,000 vol $7.21 each |
||
Filed 2017-03-30 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$21,675
+2,949 vol $7.35 each |
||
Filed 2017-03-30 Tx date 2016-09-12 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-83,000
-10,000 vol $8.30 each |
74,071 | |
Filed 2017-03-30 Tx date 2016-09-12 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$83,000
+10,000 vol $8.30 each |
||
Filed 2017-03-30 Tx date 2017-03-23 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$468,650
+65,000 vol $7.21 each |
||
Filed 2017-03-30 Tx date 2017-03-23 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-162,772.96
-22,576 vol $7.21 each |
87,324 | |
Filed 2017-03-30 Tx date 2017-03-23 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$162,772
+22,576 vol $7.21 each |
||
Filed 2017-03-30 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$21,675
+2,949 vol $7.35 each |
77,020 | |
Filed 2017-03-30 Tx date 2017-03-23 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-468,650
-65,000 vol $7.21 each |
12,020 | |
Filed 2017-03-27 Tx date 2017-03-23 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$468,650
+65,000 vol $7.21 each |
197,476 | |
Filed 2017-03-24 Tx date 2017-03-20 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
10 - Acquisition or disposition in the public market
|
$-775.00
-100 vol $7.75 each |
-624 | |
Filed 2017-03-24 Tx date 2017-03-23 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$162,772
+22,576 vol $7.21 each |
132,476 | |
Filed 2017-03-24 Tx date 2017-03-23 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$468,650
+65,000 vol $7.21 each |
109,900 | |
Filed 2017-03-20 Tx date 2017-03-17 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$29,640
+3,900 vol $7.60 each |
17,400 | |
Filed 2017-03-20 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$20,146
+2,741 vol $7.35 each |
7,418 | |
Filed 2017-03-20 Tx date 2017-03-17 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$29,640
+3,900 vol $7.60 each |
-524 | |
Filed 2017-03-20 Tx date 2017-03-17 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$354,900
+3,900 vol $91.00 each |
-4,424 | |
Filed 2017-03-18 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$85,480
+11,630 vol $7.35 each |
302,874 | |
Filed 2017-03-17 Tx date 2016-08-22 |
$RX
BioSyent Inc. |
Montador, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$12,500
+25,000 vol $0.50 each |
||
Filed 2017-03-17 Tx date 2016-08-22 |
$RX
BioSyent Inc. |
Montador, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-12,500
-25,000 vol $0.50 each |
6,676 | |
Filed 2017-03-16 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$21,675
+2,949 vol $7.35 each |
97,020 | |
Filed 2017-03-15 Tx date 2017-03-14 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$34,596
+4,707 vol $7.35 each |
20,025 | |
Filed 2017-03-15 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$9,158
+1,246 vol $7.35 each |
7,082 | |
Filed 2017-03-15 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$14,655
+1,994 vol $7.35 each |
3,885 | |
Filed 2017-03-15 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Montador, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$9,158
+1,246 vol $7.35 each |
57,922 | |
Filed 2017-03-15 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$9,158
+1,246 vol $7.35 each |
47,922 | |
Filed 2017-03-15 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$20,300
+2,762 vol $7.35 each |
9,880 | |
Filed 2016-12-29 Tx date 2016-12-29 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,610
-200 vol $8.05 each |
281,500 | |
Filed 2016-12-29 Tx date 2016-12-28 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,610
-200 vol $8.05 each |
281,700 | |
Filed 2016-12-12 Tx date 2016-12-02 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$33,000
+300,000 vol $0.11 each |
591,244 | |
Filed 2016-12-12 Tx date 2016-12-12 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$-2,400,000
-300,000 vol $8.00 each |
291,244 | |
Filed 2016-11-25 Tx date 2016-11-25 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,855
-1,100 vol $8.05 each |
281,900 | |
Filed 2016-11-25 Tx date 2016-11-25 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,000
-2,000 vol $8.00 each |
283,000 | |
Filed 2016-10-05 Tx date 2016-09-29 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$83,853
+9,900 vol $8.47 each |
44,900 | |
Filed 2016-09-29 Tx date 2016-09-29 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,800
-2,000 vol $8.40 each |
97,200 | |
Filed 2016-09-19 Tx date 2016-09-12 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,699
+10,000 vol $0.57 each |
35,000 | |
Filed 2016-09-13 Tx date 2016-09-12 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$83,000
+10,000 vol $8.30 each |
94,071 | |
Filed 2016-09-12 Tx date 2016-08-22 |
$RX
BioSyent Inc. |
Montador, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$205,500
+25,000 vol $8.22 each |
||
Filed 2016-09-12 Tx date 2016-08-22 |
$RX
BioSyent Inc. |
Montador, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$204,999
+25,000 vol $8.20 each |
75,000 | |
Filed 2016-09-10 Tx date 2016-08-22 |
$RX
BioSyent Inc. |
Montador, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$205,500
+25,000 vol $8.22 each |
75,000 | |
Filed 2016-09-08 Tx date 2016-09-08 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,680
-800 vol $8.35 each |
13,500 | |
Filed 2016-08-29 Tx date 2016-08-22 |
$RX
BioSyent Inc. |
Montador, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$12,500
+25,000 vol $0.50 each |
56,676 | |
Filed 2016-06-10 Tx date 2016-06-10 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,500
-1,000 vol $7.50 each |
14,300 | |
Filed 2016-06-09 Tx date 2016-06-08 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,750
-1,700 vol $7.50 each |
15,300 | |
Filed 2016-03-31 Tx date 2016-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,414
+992 vol $4.45 each |
152,192 | |
Filed 2016-03-31 Tx date 2016-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,549
+3,900 vol $0.91 each |
151,200 | |
Filed 2016-03-29 Tx date 2016-03-24 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,591
+3,100 vol $6.96 each |
1,580,800 | |
Filed 2016-03-29 Tx date 2016-03-29 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,014
+2,000 vol $7.01 each |
1,582,800 | |
Filed 2016-03-24 Tx date 2016-03-24 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,200
-2,000 vol $7.10 each |
99,200 | |
Filed 2016-03-23 Tx date 2016-03-23 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,200
-2,000 vol $7.10 each |
101,200 | |
Filed 2016-03-23 Tx date 2016-03-23 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,127
-300 vol $7.09 each |
103,200 | |
Filed 2016-03-22 Tx date 2016-03-21 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,160
-4,000 vol $7.04 each |
103,500 | |
Filed 2016-03-16 Tx date 2016-03-16 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,740
-2,000 vol $6.87 each |
107,500 | |
Filed 2016-03-09 Tx date 2016-03-09 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,776
-4,000 vol $6.94 each |
109,500 | |
Filed 2016-02-25 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,923
+1,278 vol $6.20 each |
1,891 | |
Filed 2016-02-25 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,316
+1,180 vol $6.20 each |
||
Filed 2016-02-25 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$12,443
+2,007 vol $6.20 each |
7,118 | |
Filed 2016-02-25 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
5,111 | ||
Filed 2016-02-24 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
613 | ||
Filed 2016-02-24 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,316
+1,180 vol $6.20 each |
1,793 | |
Filed 2016-02-18 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,613
+1,228 vol $6.20 each |
-8,324 | |
Filed 2016-02-18 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$13,658
+2,203 vol $6.20 each |
84,071 | |
Filed 2016-02-18 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$12,796
+2,064 vol $6.20 each |
9,460 | |
Filed 2016-02-18 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,613
+1,228 vol $6.20 each |
46,676 | |
Filed 2016-02-18 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$6,398
+1,032 vol $6.20 each |
||
Filed 2016-02-17 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$53,053
+8,557 vol $6.20 each |
291,244 | |
Filed 2016-02-17 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,613
+1,228 vol $6.20 each |
116,676 | |
Filed 2016-02-17 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$6,398
+1,032 vol $6.20 each |
8,428 | |
Filed 2016-02-17 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$11,780
+1,900 vol $6.20 each |
4,677 | |
Filed 2016-02-17 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$23,857
+3,848 vol $6.20 each |
15,318 | |
Filed 2016-02-16 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,613
+1,228 vol $6.20 each |
5,836 | |
Filed 2016-02-16 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Montador, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,498
+1,228 vol $6.11 each |
31,676 | |
Filed 2016-01-21 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$33,000
+300,000 vol $0.11 each |
||
Filed 2016-01-21 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-33,000
-300,000 vol $0.11 each |
282,687 | |
Filed 2016-01-20 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$33,000
+300,000 vol $0.11 each |
957,500 | |
Filed 2016-01-18 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$33,000
+300,000 vol $0.11 each |
882,687 | |
Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-4,400
-40,000 vol $0.11 each |
-9,552 | |
Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
Filed 2016-01-14 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
70,448 | |
Filed 2016-01-14 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
150,448 | |
Filed 2016-01-14 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
110,448 | |
Filed 2016-01-14 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$252,000
+40,000 vol $6.30 each |
285,000 | |
Filed 2015-08-31 Tx date 2015-08-24 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,300
+30,000 vol $0.11 each |
657,500 | |
Filed 2015-08-31 Tx date 2015-08-24 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$3,300
+30,000 vol $0.11 each |
582,687 | |
Filed 2015-08-21 Tx date 2015-08-17 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
7,396 | ||
Filed 2015-06-27 Tx date 2015-06-23 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,200
-2,000 vol $8.10 each |
1,577,700 | |
Filed 2015-06-22 Tx date 2015-06-22 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,560
-4,000 vol $8.14 each |
113,500 | |
Filed 2015-06-19 Tx date 2015-06-17 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,040
-4,000 vol $8.01 each |
117,500 | |
Filed 2015-06-15 Tx date 2015-06-15 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,040
-4,000 vol $8.01 each |
121,500 | |
Filed 2015-05-28 Tx date 2015-05-21 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-454,350
-65,000 vol $6.99 each |
115,448 | |
Filed 2015-05-28 Tx date 2015-05-21 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-454,350
-65,000 vol $6.99 each |
||
Filed 2015-05-26 Tx date 2015-05-21 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-454,350
-65,000 vol $6.99 each |
115,448 | |
Filed 2015-05-26 Tx date 2015-05-21 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$454,350
+65,000 vol $6.99 each |
125,500 |